Symptoms and signs involving the nervous and musculoskeletal systems

R18_SYMPTOMS_SIGNS_INVOLVI_NERVOUS_MUSCULOS_SYSTEMS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R25-R29 Cause of death: ICD-10 — R25-R29 2 out of 7 registries used, show all original rules.	31382
4. Check minimum number of events None	31382
5. Include endpoints R18_ABNORMAL_INVOLU_MOVEM R18_ABNORMALITI_GAIT_MOBIL R18_OTHER_LACK_COORD R18_OTHER_SYMPTOMS_SIGNS_INVOLVI_NERVOUS_MUSCULOS_SYSTEMS	31382
6. Filter based on genotype QC (FinnGen only)	30478

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R
Name in latin: Symptomata et signa ad systema nervosum et systema musculosceletale pertinentia

NAME	R18_SYMPTOMS_SIGNS_INVOLVI_NERVOUS_MUSCULOS_SYSTEMS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	R18_ABNORMAL_INVOLU_MOVEM\|R18_ABNORMALITI_GAIT_MOBIL\|R18_OTHER_LACK_COORD\|R18_OTHER_SYMPTOMS_SIGNS_INVOLVI_NERVOUS_MUSCULOS_SYSTEMS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R2[5-9]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R2[5-9]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Symptoms and signs involving the nervous and musculoskeletal systems based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	30478	17826	12652
Unadjusted period prevalence (%)	6.10	6.32	5.80
Median age at first event (years)	56.98	52.99	62.60

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
31382: Matched controls
313636

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

320.4

7161

45898

M03BX02

ATC

tizanidine; oral

1.6

319.0

18465

149058

N03AX11

ATC

topiramate; oral

3.8

318.1

1004

2712

A02BC05

ATC

esomeprazole; systemic

1.6

317.6

12198

89599

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.4

312.2

2349

10283

P29

ICPC

Psychological sympt/compl other

2.4

310.5

2323

10143

R52.9

ICD-10 Finland

Pain, unspecified

2.1

309.5

3257

16356

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

309.3

13330

100366

B01AC04

ATC

clopidogrel; oral

1.9

308.1

4903

28397

S06.0

ICD-10 Finland

Concussion

2.2

307.7

3740

18026

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.6

307.7

2360

9566

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.4

307.7

1335

4046

R52.2

ICD-10 Finland

Other chronic pain

3.8

307.7

1626

4410

SPAT1310

SPAT

Counselling related to known health issue

1.6

307.7

9853

68144

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

4.4

307.7

1039

2412

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

4.4

307.7

1307

3065

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.1

307.7

10141

57539

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

307.7

8920

59859

Z2445

NOMESCO Finland

Psychologist

3.5

307.7

1680

4943

L03

ICPC

Low back symptom/complaint

1.8

307.7

8767

56152

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

40.4

307.7

446

112

R26.0

ICD-10 Finland

Ataxic gait

87.3

307.7

354

N03AF01

ATC

carbamazepine; oral, rectal

2.8

307.7

1802

6648

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.0

307.7

3934

14474

G72.9

ICD-10 Finland

Myopathy, unspecified

8.4

307.7

464

561

G44.2

ICD-10 Finland

Tension-type headache

2.3

307.7

5008

23662

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.6

307.7

3784

15980

SPAT1254

SPAT

Administration of medicine

2.0

307.7

4979

27243

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.2

307.7

3594

12243

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

307.7

9781

65185

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.8

307.7

3080

8658

SPAT1263

SPAT

Sampling

1.7

307.7

13227

95563

A02BC02

ATC

pantoprazole; systemic

1.8

307.7

21053

168327

N28

ICPC

Limited function/disability (N)

4.9

307.7

754

1574

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.1

307.7

2615

8804

G40.9

ICD-10 Finland

Epilepsy, unspecified

4.1

307.7

1535

3848

R1250

NOMESCO Finland

Evaluation of functional capability

5.2

307.7

1140

2264

A04

ICPC

Weakness/tiredness general

2.0

307.7

4942

27187

TAB00

NOMESCO Finland

Lumbar puncture

5.7

307.7

2726

5151

N03AX12

ATC

[U] gabapentin; oral

3.0

307.7

7146

28140

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

4.3

307.7

1624

3913

SPAT1301

SPAT

No procedures

1.8

307.7

10149

67213

G35

ICD-10 Finland

Multiple sclerosis

5.1

307.7

743

1491

N06AB06

ATC

sertraline; oral

2.1

307.7

3651

18781

Z3231

NOMESCO Finland

Registered nurse

1.7

307.7

8633

56790

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.5

307.7

2203

6634

R25.2

ICD-10 Finland

Cramp and spasm

12.7

307.7

2254

1901

N05AH03

ATC

olanzapine; systemic

2.6

307.7

2142

8576

N04BC05

ATC

pramipexole; oral

2.5

307.7

2709

11326

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.8

307.7

3770

14834

Z71.8

ICD-10 Finland

Other specified counselling

1.7

307.7

9811

64948

SPAT1240

SPAT

Therapeutic discussion

2.2

307.7

3527

17332

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

307.7

5915

32726

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

5.2

307.7

1924

3885

R55

ICD-10 Finland

Syncope and collapse

2.3

307.7

3953

18402

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.4

307.7

2487

10960

L17

ICPC

Foot/toe symptom/complaint

1.7

307.7

8850

59557

XA402

NOMESCO Finland

ENMG

3.8

307.7

1018

2728

R29.2

ICD-10 Finland

Abnormal reflex

63.9

307.7

197

N03AX09

ATC

lamotrigine; oral

3.6

307.7

2097

6105

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.3

307.7

2843

12950

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.4

307.7

4939

22837

N06AA09

ATC

amitriptyline; systemic

2.5

307.7

3429

14918

N03AF02

ATC

oxcarbazepine; oral

4.0

307.7

1484

3879

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.7

307.7

2957

11755

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

307.7

12532

88046

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

307.7

9469

63952

N03AX16

ATC

[U] pregabalin

2.4

307.7

8841

44392

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.6

307.7

4248

13186

N05BA01

ATC

diazepam; systemic, rectal

2.3

307.7

4577

21996

RD211, ,

NOMESCO Finland

3.6

307.7

1853

5416

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

307.7

5420

29183

N03AE01

ATC

clonazepam; systemic

4.2

307.7

2863

7267

N06AB10

ATC

escitalopram; oral

1.9

307.7

6557

39050

N02AX02

ATC

tramadol; systemic, rectal

1.8

307.7

13742

95374

R51.80

ICD-10 Finland

Headache

2.8

307.7

6594

27152

N02BE01

ATC

paracetamol; systemic, rectal

2.1

307.7

27652

244439

R25.1

ICD-10 Finland

Tremor, unspecified

23.8

307.7

3759

1783

M79.6

ICD-10 Finland

Pain in limb

1.9

307.7

13918

91989

H53.1

ICD-10 Finland

Subjective visual disturbances

2.4

307.7

2406

10324

N05AH04

ATC

quetiapine; oral

2.4

307.7

6579

31476

M79.7

ICD-10 Finland

Fibromyalgia

3.5

307.7

1424

4196

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.1

307.7

799

1612

G20

ICD-10 Finland

Parkinson disease

5.1

307.7

1616

3315

N06AX16

ATC

venlafaxine; oral

2.4

307.7

5241

24235

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

5.8

307.7

630

1105

SPAT1229

SPAT

Assessment of need for aid

2.6

307.7

2847

11566

G25.0

ICD-10 Finland

Essential tremor

4.6

307.7

1214

2723

R42

ICD-10 Finland

Dizziness and giddiness

2.4

307.7

8948

44009

N05BA04

ATC

oxazepam; oral

1.9

307.7

8689

51923

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.5

307.7

2421

10220

M54.5

ICD-10 Finland

Low back pain

1.9

307.7

11874

76422

SPAT1216

SPAT

Assessment of functional ability

2.2

307.7

5529

27258

Z00.0

ICD-10 Finland

General medical examination

2.1

307.7

6804

36923

M54.4

ICD-10 Finland

Lumbago with sciatica

2.0

307.7

5931

32701

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

307.7

12276

80004

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

6.6

307.7

644

995

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

624.0

307.7

21305

1059

N03AG01

ATC

valproic acid; systemic, rectal

3.4

307.7

2594

8104

N06AB04

ATC

citalopram; systemic

2.0

307.7

6963

39461

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

8.2

307.7

710

886

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.3

307.7

2741

12466

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

307.7

9177

56214

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.3

307.7

3331

15506

N06AX11

ATC

mirtazapine; oral

2.0

307.7

11510

71386

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

4.0

307.7

2519

6761

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

6.8

307.7

571

855

M03BX01

ATC

baclofen; systemic

5.0

307.7

862

1767

R53

ICD-10 Finland

Malaise and fatigue

2.3

307.7

9144

47508

N29

ICPC

Neurological sympt/complt other

4.3

307.7

857

2026

AA1AD

NOMESCO Finland

CT of head and brain

2.4

307.7

10356

52860

N99

ICPC

Neurological disease other

5.9

307.7

595

1031

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.1

307.7

4884

24862

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.1

307.7

3291

16269

SPAT1252

SPAT

Overall medication plan or its review

2.5

307.7

2357

9998

L28

ICPC

Limited function/disability (L)

2.5

307.7

6688

31168

R03AC02

ATC

salbutamol; inhalant

1.6

307.7

16711

130969

A01

ICPC

Pain general/multiple sites

2.2

307.7

3067

14764

R27.0

ICD-10 Finland

Ataxia, unspecified

114.8

307.7

575

NXL00

NOMESCO Finland

Biopsy of muscle

16.0

307.7

288

181

M48.0

ICD-10 Finland

Spinal stenosis

2.3

307.7

4325

20263

R26.2

ICD-10 Finland

Difficulty in walking, not elsewhere classified

87.7

307.7

1663

200

G43.9

ICD-10 Finland

Migraine, unspecified

2.6

307.7

2084

8385

N06AX21

ATC

duloxetine; oral

2.9

307.7

4975

19036

R20.2

ICD-10 Finland

Paraesthesia of skin

3.4

307.7

3202

10158

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

307.7

4982

26653

C07AA05

ATC

propranolol; systemic

2.2

307.7

7191

38025

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

307.7

4614

21580

R06.0

ICD-10 Finland

Dyspnoea

1.9

307.7

8681

53620

N05CF01

ATC

zopiclone; oral

1.7

307.7

9829

67072

N02BF01

ATC

gabapentin; oral

2.5

307.7

2967

12357

R25.8

ICD-10 Finland

Other and unspecified abnormal involuntary movements

55.2

307.7

393

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

307.7

7455

44912

XA800

NOMESCO Finland

Neuropsychological investigation

4.4

307.7

2171

5153

A28

ICPC

Limited function/disability NOS

2.1

307.7

5531

29517

R25.3

ICD-10 Finland

Fasciculation

35.0

307.7

483

140

C07AB07

ATC

bisoprolol; oral

1.6

307.7

14278

108254

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.1

307.7

2100

7106

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.5

307.7

2202

9087

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

112.0

307.7

3355

335

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.2

307.7

3668

17942

S18

ICPC

Laceration/cut

1.6

307.7

13705

102794

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.4

307.7

2444

10715

H02AB06

ATC

prednisolone; systemic

1.6

307.7

14530

109472

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.4

306.6

1159

3525

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.4

306.4

2358

10423

M79.1

ICD-10 Finland

Myalgia

1.9

305.4

4528

25632

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.9

302.3

1516

5437

N87

ICPC

Parkinsonism

5.0

301.8

657

1333

N17

ICPC

Vertigo/dizziness

2.0

301.1

3876

20923

N05AX08

ATC

risperidone; systemic

2.2

300.7

2681

12608

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

300.1

3789

20315

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

299.6

5808

35671

RF420, ,

NOMESCO Finland

5.2

299.2

626

1227

L01

ICPC

Neck symptom/complaint

1.8

295.8

4829

28159

N02BF02

ATC

pregabalin; oral

2.5

292.1

1993

8339

A02BC03

ATC

lansoprazole; oral

1.6

291.1

8518

58330

R11

ICD-10 Finland

Nausea and vomiting

2.1

289.9

2853

13947

SPAT1153

SPAT

Removal of sutures

1.6

288.8

9361

65690

A02BC01

ATC

omeprazole; systemic

1.6

284.6

8224

56084

R13

ICD-10 Finland

Dysphagia

2.3

284.5

2256

10092

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

284.1

5398

32904

P20

ICPC

Memory disturbance

1.9

281.6

3982

22151

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.4

280.2

2101

9169

G81.9

ICD-10 Finland

Hemiplegia, unspecified

6.1

279.5

491

818

R02

ICPC

Shortness of breath/dyspnoea

1.9

279.5

4108

23137

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

14.7

276.0

246

168

M25.5

ICD-10 Finland

Pain in joint

1.6

275.9

9378

66399

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

269.9

21408

181835

RF410, ,

NOMESCO Finland

5.3

268.3

546

1044

N05AX12

ATC

aripiprazole; systemic

2.9

264.9

1341

4828

SPAT1097

SPAT

Recording of ECG

1.8

264.7

4423

25900

HMAK, ,

NOMESCO Finland

1.9

264.0

3611

19837

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.7

262.5

862

2390

A06AD11

ATC

lactulose; oral

1.8

258.9

4333

25371

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

258.0

2997

15556

N03AX14

ATC

levetiracetam; systemic

3.2

256.6

1074

3472

M54.2

ICD-10 Finland

Cervicalgia

2.1

256.4

2506

12194

-1, ,

NOMESCO Finland

1.6

256.0

9744

70526

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

255.6

5008

30700

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.4

255.2

1814

7722

RF120, ,

NOMESCO Finland

5.3

254.7

520

997

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

254.3

5486

34537

ZYC01

NOMESCO Finland

Remote contact by phone

2.3

254.0

1975

8748

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

253.5

5535

34959

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

250.8

13757

107455

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

250.2

16161

130453

N06AB03

ATC

fluoxetine; oral

1.9

249.9

3731

21066

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

249.4

13317

103406

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.6

247.6

1566

6311

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

247.6

3777

21468

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

5.4

245.1

483

897

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.0

243.8

2994

15831

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.6

242.2

817

2306

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.3

241.8

1858

8183

N02AA05

ATC

oxycodone; systemic

1.7

241.4

5070

31639

G24.9

ICD-10 Finland

Dystonia, unspecified

11.0

240.4

256

234

R07.3

ICD-10 Finland

Other chest pain

1.9

240.2

3127

16865

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

238.8

8639

61618

P03

ICPC

Feeling depressed

2.0

237.1

3003

16043

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

236.7

2717

14022

SPAT1053

SPAT

Memory test

1.8

235.9

4140

24532

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.1

235.8

2597

13203

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.2

232.0

957

3066

H53.2

ICD-10 Finland

Diplopia

2.9

231.6

1104

3843

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

231.5

7147

49104

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.3

230.7

1802

7989

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

230.7

10336

77064

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

230.7

6511

43784

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

230.1

7528

52411

SPAT1131

SPAT

Colonoscopy

2.9

228.6

1099

3844

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.6

227.4

1367

5371

G04BD12

ATC

mirabegron; oral

1.9

227.3

3477

19745

K59.09

ICD-10 Finland

Constipation, unspecified

2.2

226.8

2120

10121

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

226.7

12144

93787

N04BD01

ATC

selegiline; oral

4.4

225.3

569

1303

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

223.7

2473

12580

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.5

222.1

1474

6071

R50.9

ICD-10 Finland

Fever, unspecified

1.7

222.0

4486

27639

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

221.2

6679

45575

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.9

219.6

494

1030

J01DB01

ATC

cefalexin; oral

1.6

219.0

24938

222790

M54.6

ICD-10 Finland

Pain in thoracic spine

2.1

218.6

2269

11272

G47.3

ICD-10 Finland

Sleep apnoea

1.6

217.1

6333

42836

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

3.0

216.3

1011

3480

U04

ICPC

Incontinence urine

2.3

216.1

1654

7264

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.0

216.0

990

3371

P01

ICPC

Feeling anxious/nervous/tense

1.8

214.9

3470

20015

KMAK, ,

NOMESCO Finland

1.4

214.3

14632

117958

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

214.0

5452

35665

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.2

213.6

893

2883

C03CA01

ATC

furosemide; systemic

1.5

212.5

8279

59715

A02BA02

ATC

ranitidine; systemic

1.6

212.4

5430

35547

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

211.8

20948

180881

N05AA02

ATC

levomepromazine; systemic

2.6

210.4

1251

4886

N06AX26

ATC

vortioxetine; oral

2.1

210.0

2199

10955

R60.0

ICD-10 Finland

Localized oedema

1.8

209.3

3607

21205

G25.2

ICD-10 Finland

Other specified forms of tremor

7.1

209.2

317

453

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

208.3

12041

93907

N30.0

ICD-10 Finland

Acute cystitis

1.7

208.2

4789

30499

G43.3

ICD-10 Finland

Complicated migraine

3.8

207.8

636

1679

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.2

207.6

849

2705

R27.8

ICD-10 Finland

Other and unspecified lack of coordination

63.5

206.6

114

UJF32

NOMESCO Finland

Coloscopy

1.5

206.6

7469

52955

UKC02

NOMESCO Finland

Cystoscopy

1.7

205.7

4574

28866

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

205.6

3169

18004

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.5

205.6

725

2106

R35

ICD-10 Finland

Polyuria

2.1

204.3

2052

10060

L29

ICPC

Musculoskeletal sympt/complt other

2.0

204.3

2593

13829

R25.0

ICD-10 Finland

Abnormal head movements

89.4

203.7

107

SPAT1260

SPAT

Consultation of another employee

1.6

203.0

5234

34291

A29

ICPC

General symptom/complaint other

1.8

201.8

3686

22024

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.8

201.8

1075

3970

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

201.6

6479

44714

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

201.6

3400

19848

N01

ICPC

Headache

1.8

201.4

3295

19060

P76

ICPC

Depressive disorder

2.1

200.5

1974

9602

G54.0

ICD-10 Finland

Brachial plexus disorders

3.1

200.4

870

2871

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.1

199.6

1952

9470

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

199.2

4496

28462

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

198.9

7361

52383

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

4.9

198.4

441

910

N18

ICPC

Paralysis/weakness

3.5

197.2

695

2018

SPAT1359

SPAT

Use of symptom diary

3.0

197.1

894

3025

R26

ICD-10 Finland

Abnormalities of gait and mobility

13.9

195.7

180

130

N05CD07

ATC

temazepam; oral

1.8

193.6

3298

19296

K02.1

ICD-10 Finland

Caries of dentine

1.4

193.5

16922

141602

N04BC04

ATC

ropinirole; oral

4.7

193.1

453

978

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

6.5

191.9

315

490

R4110, ,

SPAT

1.9

191.3

2525

13632

N06AX12

ATC

bupropion; oral

2.1

190.2

2057

10359

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

190.1

11753

92343

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

188.6

2710

15039

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

188.3

3787

23217

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.4

188.1

693

2070

M54.1

ICD-10 Finland

Radiculopathy

2.5

188.0

1258

5196

183

Kela drug reimbursment

Lamotrigin and topiramate

5.1

184.8

393

781

G12.2

ICD-10 Finland

Motor neuron disease

7.4

184.3

267

363

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.4

183.6

1317

5613

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

182.7

11106

86807

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

182.7

19299

166130

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.4

182.7

1259

5270

N05BA12

ATC

alprazolam; oral

1.8

182.1

2837

16140

SPAT1234

SPAT

Support of social functional capacity

2.2

181.6

1548

7105

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

180.6

10281

79359

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.6

179.0

1100

4362

SPAT1307

SPAT

Psychosocial counselling and guidance

2.1

178.9

1823

8975

F44.4

ICD-10 Finland

Dissociative motor disorders

27.6

178.8

121

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.5

178.7

1122

4496

N05AN01

ATC

lithium; oral

3.0

177.2

787

2630

109

Kela drug reimbursment

Multiple sclerosis

4.4

177.2

450

1035

RF210, ,

NOMESCO Finland

2.8

176.9

920

3353

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.9

176.7

847

2954

N06AX03

ATC

mianserin; oral

2.3

176.6

1430

6423

SFA10

NOMESCO Finland

One-surface restoration

1.4

175.7

15629

130215

Z08

ICPC

Social welfare problem

4.1

175.4

496

1237

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

175.2

4059

25798

P99

ICPC

Psychological disorders other

2.8

175.1

923

3388

EBA00

NOMESCO Finland

Extraction of tooth

1.4

174.7

10009

77232

R05

ICPC

Cough

1.5

174.6

6817

48842

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

173.8

3717

23131

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

5.8

173.8

318

551

R41.0

ICD-10 Finland

Disorientation, unspecified

2.7

170.9

955

3612

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

170.8

6741

48370

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.6

170.8

1052

4176

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

170.7

5341

36460

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

4.7

169.6

400

867

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

168.1

3442

21161

R29.4

ICD-10 Finland

Clicking hip

22.7

167.7

122

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.1

167.2

1680

8222

Z3229

NOMESCO Finland

Other healthcare associate professional

1.9

166.4

2455

13717

N04AA02

ATC

biperiden; systemic

3.3

166.2

628

1905

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.8

165.4

2789

16228

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.3

165.3

1290

5701

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.5

165.1

581

1685

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

164.9

6859

49689

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

164.9

2639

15116

J01MA02

ATC

ciprofloxacin; systemic

1.4

164.3

10855

85659

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

164.1

3208

19466

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

8.5

163.8

210

247

J01AA02

ATC

doxycycline; systemic

1.4

163.7

22431

199883

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

163.3

3832

24401

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

4.7

162.6

376

802

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

162.4

11777

94372

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.5

161.6

1102

4587

R5110, ,

SPAT

2.0

161.5

1884

9732

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.6

161.4

5146

35229

XKC03

NOMESCO Finland

Water cystometry

2.6

160.5

954

3720

R03DC03

ATC

montelukast; oral

1.6

160.3

4609

30818

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.7

160.2

907

3453

R52.1

ICD-10 Finland

Chronic intractable pain

4.7

159.7

376

814

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.3

159.3

621

1921

L08

ICPC

Shoulder symptom/complaint

1.5

158.3

5948

42156

I95.1

ICD-10 Finland

Orthostatic hypotension

2.4

157.8

1109

4680

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.7

157.3

883

3346

J01EA01

ATC

trimethoprim; systemic

1.5

156.3

7248

53545

M01AH01

ATC

celecoxib; oral

1.6

156.1

4883

33259

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.3

155.9

599

1836

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.5

155.5

994

4014

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.3

155.3

1262

5673

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

153.0

1404

6630

SPAT1262

SPAT

Handing over of treatment supplies

1.5

152.2

4797

32709

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

152.2

3768

24283

R06AE07

ATC

cetirizine; oral

1.4

152.0

12335

100347

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.0

151.7

676

2263

XKD00

NOMESCO Finland

Uroflowmetry

1.6

151.5

4184

27681

SPAT1312

SPAT

General health counselling

1.4

150.9

8983

69366

K30

ICD-10 Finland

Functional dyspepsia

1.7

150.8

3141

19363

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.2

150.6

607

1916

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

4.0

150.5

431

1085

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.0

150.3

673

2259

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.6

149.9

494

1372

N05BA06

ATC

lorazepam; systemic, sublingual

2.1

149.7

1460

7058

M01AC06

ATC

meloxicam; systemic, rectal

1.4

149.6

9759

76526

G62.8

ICD-10 Finland

Other specified polyneuropathies

4.8

149.2

337

705

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

148.8

2815

16901

R00.2

ICD-10 Finland

Palpitations

1.8

148.7

2203

12309

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2.8

148.5

756

2723

N06AB05

ATC

paroxetine; oral

2.0

148.3

1690

8653

RS340, ,

NOMESCO Finland

10.3

148.1

165

161

P01AB01

ATC

metronidazole; oral, rectal

1.4

148.1

11074

88791

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

146.5

5388

37944

SPAT1050

SPAT

Extensive neurological examination

2.9

146.4

704

2459

L12

ICPC

Hand/finger symptom/complaint

1.6

146.1

4475

30294

C10AA01

ATC

simvastatin; oral

1.4

145.4

11106

89275

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.5

144.9

910

3643

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

144.7

2777

16735

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.7

144.7

2828

17128

C07AB02

ATC

metoprolol; systemic

1.5

144.3

5353

37748

P06

ICPC

Sleep disturbance

1.7

142.8

3218

20234

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.8

142.5

724

2605

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.3

142.3

1072

4663

G40.10

ICD-10 Finland

Simple partial seizures

5.0

142.1

306

615

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.3

141.9

1128

5021

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

141.5

2989

18479

SPAT1360

SPAT

Extensive global examination

1.9

141.3

2041

11306

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

141.2

3610

23417

D01

ICPC

Abdominal pain/cramps general

1.6

141.1

3293

20886

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.6

140.9

463

1283

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

140.7

2015

11132

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

6.9

140.0

217

318

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

139.5

1678

8750

K07.60

ICD-10 Finland

Snapping jaw

2.1

139.4

1465

7280

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.1

139.4

598

1958

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

139.3

1279

6037

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

139.3

4255

28760

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

4.0

138.3

397

1001

SFA20

NOMESCO Finland

Two-surface restoration

1.3

138.0

16274

139473

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

136.8

2721

16544

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

136.7

8937

69862

ZY010

NOMESCO Finland

Hospital outpatient

2.0

136.6

1457

7279

WX290

NOMESCO Finland

Other blockage of nerve

1.4

136.6

12675

104728

XCK00

NOMESCO Finland

Perimetry

1.9

136.3

1786

9585

H13

ICPC

Plugged feeling ear

1.5

135.4

5153

36476

N05AF03

ATC

chlorprothixene; systemic

2.7

135.3

773

2955

R33

ICD-10 Finland

Retention of urine

1.8

135.3

2125

12076

N05CF02

ATC

zolpidem; oral

1.5

135.2

4679

32474

Z3226

NOMESCO Finland

Physiotherapist

1.5

134.9

4945

34733

R5599

NOMESCO Finland

Other rehabilitation service

2.6

134.4

829

3290

L02

ICPC

Back symptom/complaint

1.7

134.2

2748

16835

N86

ICPC

Multiple sclerosis

5.4

134.2

268

504

J01FF01

ATC

clindamycin; systemic

1.4

134.1

7357

55778

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.7

134.1

733

2740

WZC30

NOMESCO Finland

Teaching

1.5

133.9

4238

28846

R03BA01

ATC

beclometasone; inhalant

1.6

133.6

3813

25358

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.3

133.6

1020

4461

M01AE02

ATC

naproxen; oral, rectal

1.3

133.4

15875

135934

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.5

133.4

861

3492

N05AB03

ATC

perphenazine; systemic, rectal

2.4

133.2

976

4193

Z00.8

ICD-10 Finland

Other general examinations

1.8

133.2

2205

12726

A11

ICPC

Chest pain NOS

1.8

133.1

2235

12953

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.7

133.0

760

2905

J02AC01

ATC

fluconazole; systemic

1.4

133.0

10762

86964

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

7.3

132.9

195

269

R51.81

ICD-10 Finland

Facial pain NOS

2.7

132.6

729

2733

RK112, ,

NOMESCO Finland

15.1

132.1

116

U02

ICPC

Urinary frequency/urgency

1.6

131.9

3839

25640

R96

ICPC

Asthma

1.7

131.7

2628

15985

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

131.2

2592

15724

E0000UV, ,

ATC

1.4

131.2

11581

94781

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.2

131.1

1132

5212

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.9

131.1

1918

10660

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.0

130.9

1402

7013

F61.0

ICD-10 Finland

Mixed personality disorders

3.2

130.7

538

1719

J45.8

ICD-10 Finland

Mixed asthma

2.4

130.5

919

3879

M01AH05

ATC

etoricoxib; oral

1.3

130.1

17034

147664

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

130.0

10033

80400

K90

ICPC

Stroke/cerebrovascular accident

2.5

129.8

824

3315

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.1

129.1

1296

6329

A03

ICPC

Fever

1.5

128.6

4608

32179

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

127.6

16271

140331

R03BA05

ATC

fluticasone; inhalant

1.5

126.8

4996

35556

F34.1

ICD-10 Finland

Dysthymia

2.3

126.8

1025

4593

H03AA01

ATC

levothyroxine sodium; systemic

1.4

126.3

6275

46663

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

126.2

4373

30316

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

125.7

1766

9687

L14

ICPC

Leg/thigh symptom/complaint

1.8

125.7

2184

12777

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.4

125.5

916

3928

L13

ICPC

Hip symptom/complaint

1.5

124.9

4771

33735

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

124.6

2453

14859

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.1

124.4

1198

5757

X58

ICD-10 Finland

Exposure to other specified factors

1.6

124.4

3759

25293

C08CA01

ATC

amlodipine; oral

1.4

124.2

10006

80570

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

4.1

124.1

348

863

R4120

NOMESCO Finland

Occupational therapy

1.9

123.6

1798

9970

ZXY02

NOMESCO Finland

Neuropsychologist

5.5

123.6

238

433

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

123.5

3110

20059

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

123.2

3755

25309

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

6.9

123.2

190

277

S29

ICPC

Skin symptom/complaint other

1.5

122.9

5163

37186

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.2

122.8

1134

5362

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.0

122.8

1331

6685

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

8.3

122.7

161

195

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.9

122.5

574

1976

W19

ICD-10 Finland

Unspecified fall

1.7

122.5

2662

16548

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

3.9

122.2

362

934

NA7BT

NOMESCO Finland

Injection to spinal facet joint with radiological guidance

6.6

122.1

195

295

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

122.0

3667

24638

S22.3

ICD-10 Finland

Fracture of rib

1.8

121.6

1882

10636

N06AA12

ATC

doxepin; systemic

2.0

121.6

1388

7101

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

121.4

1255

6195

L86

ICPC

Back syndrome with radiating pain

1.9

121.0

1664

9062

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.7

120.9

2533

15594

S15

ICPC

Foreign body in skin

1.9

120.8

1752

9705

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.3

120.6

455

1379

AN1

Coronary angiography

1.6

120.4

2846

18066

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

4.3

120.4

311

725

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

120.3

2378

14413

G04CA02

ATC

tamsulosin; oral

1.4

120.2

5895

43677

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.4

120.1

444

1329

N06AA10

ATC

nortriptyline; systemic

2.8

120.0

631

2311

SFA30

NOMESCO Finland

Three-surface restoration

1.3

119.8

11248

92526

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.0

119.8

1404

7249

L16

ICPC

Ankle symptom/complaint

1.6

119.6

3070

19885

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.6

119.4

2737

17240

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

118.6

1937

11122

PEN23

NOMESCO Finland

Plastic repair of femoral artery

4.2

118.4

315

751

H57.1

ICD-10 Finland

Ocular pain

2.2

118.3

1048

4874

N03AX18

ATC

lacosamide; systemic

4.4

118.1

298

682

M54.3

ICD-10 Finland

Sciatica

1.9

118.1

1626

8857

G43.8

ICD-10 Finland

Other migraine

3.2

118.0

485

1549

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

117.3

5613

41380

C10AA05

ATC

atorvastatin; oral

1.3

117.2

10860

89087

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

117.2

1589

8614

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.2

116.7

966

4370

L19

ICPC

Muscle symptom/complaint NOS

2.4

116.7

817

3439

G04BD08

ATC

solifenacin; oral

1.8

116.5

1767

9922

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

3.5

116.2

398

1134

UDC00

NOMESCO Finland

Ear microscopy

1.8

116.1

2053

12061

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

116.0

7497

58178

UJD02

NOMESCO Finland

Gastroscopy

2.0

115.7

1306

6652

H46

ICD-10 Finland

Optic neuritis

4.2

115.4

311

749

J01CA04

ATC

amoxicillin; systemic

1.4

115.2

23908

219565

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

3.7

115.1

362

974

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

114.7

3394

22701

R21

ICPC

Throat symptom/complaint

1.4

114.0

5644

41837

R06.4

ICD-10 Finland

Hyperventilation

3.0

113.9

512

1722

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

113.9

6898

52938

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.1

113.3

489

1607

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

112.7

1493

8029

N07AA02

ATC

pyridostigmine; systemic

5.7

112.7

211

374

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

112.2

1498

8077

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

112.0

3607

24569

N06AX22

ATC

agomelatine; oral

2.6

111.6

667

2606

A05

ICPC

Feeling ill

1.8

111.3

1678

9401

M01AB05

ATC

diclofenac; systemic, rectal

1.3

111.0

18348

162533

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.8

111.0

1687

9475

SPAT1243

SPAT

Psychiatric/psychological examination

2.4

111.0

756

3142

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

5.3

110.9

223

422

H01

ICPC

Ear pain/earache

1.6

110.8

3119

20619

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

2.2

110.7

1017

4798

M01AX17

ATC

nimesulide; oral

1.4

110.4

6140

46412

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.5

110.1

377

1074

N04BD02

ATC

rasagiline; oral

4.4

109.9

281

650

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

109.9

3002

19708

M35.7

ICD-10 Finland

Hypermobility syndrome

3.2

109.7

446

1415

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

109.5

13229

112277

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

109.5

1747

9956

DFF00

NOMESCO Finland

Pure tone audiometry

1.6

109.5

2607

16562

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

109.2

7139

55410

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.9

109.0

527

1846

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

108.9

6949

53719

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.9

108.6

1455

7853

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

108.5

5653

42234

J01FA06

ATC

roxithromycin; oral

1.3

108.5

10598

87326

F45.0

ICD-10 Finland

Somatization disorder

5.9

108.3

195

333

R01AD09

ATC

mometasone; nasal

1.3

108.2

12305

103528

ZXE00

NOMESCO Finland

One hour or less

1.3

108.2

10558

86974

D07AC01

ATC

betamethasone; topical

1.3

107.8

9642

78438

J01DA01

ATC

[U] cefalexin

1.3

107.8

17180

151155

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

107.7

14453

124300

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

3.9

106.8

312

797

L03AX13

ATC

glatiramer acetate; parenteral

5.8

106.8

196

341

PLAK1, ,

NOMESCO Finland

3.6

106.7

360

1016

XCH00

NOMESCO Finland

Eye pressure measurement

2.0

106.5

1275

6626

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

106.4

3359

22764

R51

ICD-10 Finland

Headache

1.9

106.4

1505

8264

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

105.9

4279

30496

N05BA09

ATC

clobazam; oral

4.6

105.9

250

543

J01CA08

ATC

pivmecillinam; oral

1.3

105.8

10773

89193

SPAT1255

SPAT

Intravenous administration of medicine

1.8

105.7

1806

10499

S01

ICPC

Pain/tenderness of skin

2.0

105.5

1263

6565

C10AX09

ATC

ezetimibe; oral

1.5

105.4

3886

27198

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

105.4

11371

94885

G11.9

ICD-10 Finland

Hereditary ataxia, unspecified

12.4

104.9

103

Z01.2

ICD-10 Finland

Dental examination

1.3

104.9

12393

104664

R01AD01

ATC

beclometasone; nasal

1.5

104.8

3932

27614

U01

ICPC

Dysuria/painful urination

1.7

104.8

2075

12566

J01FA10

ATC

azithromycin; systemic

1.3

104.8

15854

138304

Z11

ICPC

Compliance/being ill problem

4.4

104.6

267

617

N27

ICPC

Fear of neurological disease other

3.0

104.5

483

1650

G82.2

ICD-10 Finland

Paraplegia, unspecified

5.8

104.3

192

335

N05BE01

ATC

buspirone; oral

2.3

104.0

797

3490

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.0

103.9

1242

6451

RS221, ,

NOMESCO Finland

3.0

103.9

459

1529

G50.1

ICD-10 Finland

Atypical facial pain

2.8

103.4

537

1954

G44.0

ICD-10 Finland

Cluster headache syndrome

3.5

103.1

357

1025

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

103.0

6203

47438

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

103.0

2850

18751

F44.7

ICD-10 Finland

Mixed dissociative [conversion] disorders

14.1

102.9

M89.0

ICD-10 Finland

Algoneurodystrophy

3.9

102.8

300

766

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

4.2

102.3

275

661

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

102.1

1312

6982

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.8

102.1

534

1951

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.2

101.9

891

4120

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

101.9

3388

23202

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

101.8

3245

22024

G61.0

ICD-10 Finland

Guillain-Barré syndrome

6.5

101.7

166

257

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

101.3

1569

8858

N06AG02

ATC

moclobemide; oral

2.0

101.0

1145

5839

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.1

100.4

967

4644

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

100.4

2387

15144

G24.3

ICD-10 Finland

Spasmodic torticollis

3.7

100.3

327

902

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.2

100.1

834

3782

G24.8

ICD-10 Finland

Other dystonia

6.7

99.8

157

234

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.0

99.8

1120

5691

A03FA02

ATC

cisapride; oral, rectal

1.7

99.5

1940

11695

Z03

ICPC

Housing/neighbourhood problem

4.5

99.1

241

536

R29.3

ICD-10 Finland

Abnormal posture

32.0

99.0

K05

ICPC

Irregular heartbeat other

2.2

98.8

871

4041

K59.0

ICD-10 Finland

Constipation

1.8

98.7

1508

8476

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

2.9

98.7

466

1611

M02AA07

ATC

piroxicam; topical

1.3

98.5

9319

76181

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

98.4

7052

55367

P74

ICPC

Anxiety disorder/anxiety state

2.0

98.2

1102

5598

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.9

98.1

469

1633

U05

ICPC

Urination problems other

1.9

98.1

1330

7203

L15

ICPC

Knee symptom/complaint

1.4

98.1

6181

47563

G72.8

ICD-10 Finland

Other specified myopathies

2.9

98.0

463

1602

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

97.7

1987

12112

R05

ICD-10 Finland

Cough

1.4

97.5

5595

42397

R01AD12

ATC

fluticasone furoate; nasal

1.3

97.4

8236

66241

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.9

97.4

1257

6698

D11

ICPC

Diarrhoea

1.5

97.4

3053

20636

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

97.2

1835

10964

RS314, ,

NOMESCO Finland

8.9

97.0

120

135

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.6

96.9

565

2181

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.2

96.7

825

3777

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

96.7

9229

75492

R06.5

ICD-10 Finland

Mouth breathing

1.6

96.4

2268

14345

M54.8

ICD-10 Finland

Other dorsalgia

1.9

96.2

1201

6328

R5120

NOMESCO Finland

Preparation of an aid

2.3

96.2

766

3408

RS130, ,

NOMESCO Finland

8.6

96.0

122

142

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.2

96.0

860

4016

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

95.7

5734

43740

R47.1

ICD-10 Finland

Dysarthria and anarthria

3.8

95.6

292

770

R46.8

ICD-10 Finland

Other symptoms and signs involving appearance and behaviour

12.2

95.6

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

3.7

95.4

299

803

L03AB07

ATC

interferon beta-1a; parenteral

4.7

95.4

219

465

U07

ICPC

Urine symptom/complaint other

1.7

95.3

1933

11773

M01AH02

ATC

rofecoxib; oral

1.5

95.0

3205

21993

R03BB04

ATC

tiotropium bromide; inhalant

1.6

95.0

2561

16731

L04

ICPC

Chest symptom/complaint

1.8

95.0

1627

9458

R01AD08

ATC

fluticasone; nasal

1.3

94.8

7448

59228

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

94.7

3996

28662

R25

ICD-10 Finland

Abnormal involuntary movements

27.9

94.7

C10AA07

ATC

rosuvastatin; oral

1.3

94.7

7972

64029

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.2

94.5

857

4020

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

94.1

2774

18493

SPAT1325

SPAT

Vaccination

1.3

93.9

8959

73206

SPAT1059

SPAT

Spirometry at the office

1.9

93.8

1325

7269

ZXD05

NOMESCO Finland

Urgent procedure

1.3

93.7

8073

65032

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.6

93.6

569

2242

N07BB01

ATC

disulfiram; oral

2.0

93.4

1068

5460

XF404

NOMESCO Finland

Ambulatory ECG

1.6

93.3

2254

14345

SPAT1101

SPAT

Orthostatic test

2.0

93.3

1113

5775

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

93.2

5709

43678

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

92.4

5239

39572

J46

ICD-10 Finland

Status asthmaticus

2.2

92.2

784

3584

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.4

92.2

639

2677

T78.4

ICD-10 Finland

Allergy, unspecified

1.9

92.1

1215

6520

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.7

91.7

1993

12354

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.6

91.6

549

2148

K04

ICPC

Palpitations/awareness of heart

1.8

91.4

1380

7727

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.3

91.1

709

3124

K07

ICPC

Swollen ankles/oedema

1.9

91.0

1177

6274

D06

ICPC

Abdominal pain localized other

1.6

90.6

2282

14668

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

5.0

90.4

194

389

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

90.4

2574

17018

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

90.2

3523

24884

G04BD07

ATC

tolterodine; oral

1.9

90.1

1225

6636

K29

ICPC

Cardiovascular sympt/complt other

1.9

90.1

1138

6019

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.9

89.7

434

1521

AA5PD

NOMESCO Finland

CT examination of brain pefusion

3.6

89.7

295

819

S80.0

ICD-10 Finland

Contusion of knee

1.7

89.6

1898

11686

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.3

89.5

729

3274

S01.0

ICD-10 Finland

Open wound of scalp

1.6

89.4

1964

12204

N88

ICPC

Epilepsy

4.4

88.6

222

506

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

2.3

88.3

689

3040

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

4.7

88.2

202

428

RJ630, ,

NOMESCO Finland

11.1

88.1

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.1

87.9

370

1199

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

3.6

87.7

287

794

C01DA14

ATC

isosorbide mononitrate; oral

1.4

87.6

3717

26658

Z2446

NOMESCO Finland

Social worker

1.7

87.2

1682

10100

SGA01

NOMESCO Finland

Emergency treatment

1.4

87.2

4052

29548

R12

ICD-10 Finland

Heartburn

1.6

87.1

2053

12981

R06AX27

ATC

desloratadine; oral

1.3

86.8

7403

59429

R63.4

ICD-10 Finland

Abnormal weight loss

2.0

86.6

996

5102

G91.0

ICD-10 Finland

Communicating hydrocephalus

4.9

86.5

189

385

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.0

86.5

911

4522

SPAT1106

SPAT

Acupuncture

3.9

86.4

251

639

NJ3BG

NOMESCO Finland

MRI examination of extremities with high intensity magnet

5.9

86.4

155

264

ZX120

NOMESCO Finland

Intravenous

1.6

86.1

2405

15824

AN2

Balloon angioplasty, including several vessels

2.2

86.0

721

3277

RS142, ,

NOMESCO Finland

7.8

86.0

118

151

F32.8

ICD-10 Finland

Other depressive episodes

2.7

85.9

453

1662

KHV, ,

NOMESCO Finland

3.9

85.6

250

639

N08

ICPC

Abnormal involuntary movements

6.9

85.4

131

190

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

85.3

7649

61806

N06BA04

ATC

methylphenidate; oral

2.1

85.1

807

3852

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.0

85.0

377

1259

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

84.9

1923

12037

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.9

84.7

1107

5920

C01CA24

ATC

epinephrine; parenteral

1.7

84.5

1583

9428

EB1VA, ,

NOMESCO Finland

1.5

84.5

3130

21858

T90

ICPC

Diabetes non-insulin dependent

1.3

84.5

5927

46216

R07

ICPC

Sneezing/nasal congestion

1.7

84.4

1669

10088

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.7

84.2

1462

8527

L11

ICPC

Wrist symptom/complaint

1.6

84.1

2264

14771

SPAT1304

SPAT

Counselling and guidance related to ageing

1.7

84.0

1753

10746

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

83.9

1984

12552

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.2

83.9

725

3337

SPAT1211

SPAT

Application of soft bandage

1.6

83.7

2277

14888

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

83.7

1712

10440

A01AB09

ATC

miconazole; local oral

1.6

83.6

2188

14182

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.2

83.4

719

3306

T90.5

ICD-10 Finland

Sequelae of intracranial injury

3.2

83.3

337

1067

N06AX05

ATC

trazodone; oral

2.3

83.2

675

3027

RF220, ,

NOMESCO Finland

2.8

83.1

418

1496

N06AA06

ATC

trimipramine; systemic

2.3

83.1

628

2733

C08DA01

ATC

verapamil; systemic

1.9

83.0

1046

5526

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.3

83.0

618

2672

J45.1

ICD-10 Finland

Nonallergic asthma

1.6

82.8

1850

11539

F05.9

ICD-10 Finland

Delirium, unspecified

2.4

82.7

555

2291

G44.8

ICD-10 Finland

Other specified headache syndromes

2.8

82.4

417

1498

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

4.1

82.2

223

540

C09CA06

ATC

candesartan; oral

1.3

82.1

6007

47107

R29

ICPC

Respiratory symptom/complaint other

1.7

81.9

1713

10507

N05AD01

ATC

haloperidol; systemic

2.1

81.9

777

3710

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.2

81.5

665

2990

R09

ICPC

Sinus symptom/complaint

1.6

81.5

2036

13051

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

2.9

81.2

396

1394

SPAT1284

SPAT

Extensive health certificate

2.1

81.1

754

3571

A02BC04

ATC

rabeprazole; oral

1.6

81.0

2168

14119

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

81.0

2510

16891

B01AA03

ATC

warfarin; systemic

1.4

80.9

4624

34890

A27

ICPC

Fear of other disease NOS

1.8

80.9

1233

6920

N04BC09

ATC

rotigotine; transdermal

5.0

80.4

173

348

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.7

79.9

1432

8423

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

79.8

7576

61581

R15

ICD-10 Finland

Faecal incontinence

2.2

79.7

726

3411

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.4

79.7

3387

24271

SPAT1104

SPAT

Monitoring of emergency patient

1.7

79.6

1663

10195

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.9

79.2

1055

5676

SPAT1058

SPAT

PEF monitoring instruction

1.6

79.2

2048

13231

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

4.2

78.8

210

502

Z29

ICPC

Social problem NOS

2.3

78.6

587

2542

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

6.6

78.5

126

192

M02AA10

ATC

ketoprofen; topical

1.4

78.4

3948

29150

S70.0

ICD-10 Finland

Contusion of hip

1.9

78.4

971

5101

XQ848

NOMESCO Finland

Dermatological photography

2.1

78.3

774

3752

K08.80

ICD-10 Finland

Toothache NOS

1.6

78.1

2188

14395

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.1

78.1

775

3764

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

78.1

1172

6547

N19

ICPC

Speech disorder

2.8

78.0

388

1381

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.2

77.9

666

3051

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.7

77.8

1443

8567

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1.9

77.7

955

5003

N05AH02

ATC

clozapine; systemic

2.6

77.6

461

1797

G11.2

ICD-10 Finland

Late-onset cerebellar ataxia

14.7

77.4

K08.3

ICD-10 Finland

Retained dental root

1.6

77.4

1879

11956

TKC20

NOMESCO Finland

Catheterisation of bladder

1.6

77.3

1697

10533

B01AB05

ATC

enoxaparin; parenteral

1.3

77.2

8139

67016

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.2

77.1

645

2929

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.1

77.1

329

1075

G04BD04

ATC

oxybutynin; oral, transdermal

1.8

77.1

1285

7404

193

Kela drug reimbursment

Rasagiline

4.2

77.0

206

494

N06DA03

ATC

rivastigmine; oral, transdermal

1.9

77.0

998

5322

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

76.8

6793

54641

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.4

76.8

545

2307

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.5

76.8

512

2108

XF606

NOMESCO Finland

Ortostatic test

3.8

76.6

234

618

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.1

76.3

213

527

AA1AA

NOMESCO Finland

Head X-ray examination

3.6

76.3

249

688

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

76.2

1287

7443

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.3

76.2

586

2570

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

2.3

76.1

562

2421

D12

ICPC

Constipation

1.9

75.9

925

4832

R03BA08

ATC

ciclesonide; inhalant

1.5

75.5

2164

14306

D19

ICPC

Teeth/gum symptom/complaint

1.3

75.4

7182

58328

RP120, ,

NOMESCO Finland

29.4

75.2

J01MA14

ATC

moxifloxacin; systemic

1.5

75.1

2192

14551

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

9.1

74.9

100

N07

ICPC

Convulsion/seizure

6.4

74.9

124

195

C08CA13

ATC

lercanidipine; oral

1.4

74.8

3491

25424

A99

ICPC

Disease/condition unspecnature/site

1.5

74.7

2333

15715

G83.9

ICD-10 Finland

Paralytic syndrome, unspecified

7.8

74.5

103

133

G41.9

ICD-10 Finland

Status epilepticus, unspecified

4.2

74.4

197

469

F41.00

ICD-10 Finland

Moderate panic disorder

2.6

74.3

426

1632

G23.9

ICD-10 Finland

Degenerative disease of basal ganglia, unspecified

7.4

74.2

107

145

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.0

74.2

851

4354

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

3.3

73.7

287

888

D02

ICPC

Abdominal pain epigastric

1.7

73.6

1529

9354

G25.3

ICD-10 Finland

Myoclonus

8.0

73.5

124

F44.5

ICD-10 Finland

Dissociative convulsions

20.0

73.0

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

6.7

72.9

115

172

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.7

72.9

1266

7379

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

72.8

1587

9830

K04.08

ICD-10 Finland

Other specified pulpit

1.6

72.7

1799

11494

H53.4

ICD-10 Finland

Visual field defects

2.3

72.7

553

2414

SFA00

NOMESCO Finland

Small restoration

1.4

72.4

3409

24853

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

72.4

5775

45744

N06BA07

ATC

modafinil; oral

5.3

72.3

146

278

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.1

72.0

302

977

J01DA09

ATC

[U] cefadroxil

1.3

71.7

6698

54196

L04AX07

ATC

dimethyl fumarate; oral

5.3

71.6

144

273

SPAT1283

SPAT

Restricted health certificate

1.4

71.5

4220

31946

A02BA04

ATC

nizatidine; systemic

1.6

71.5

1805

11588

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

71.5

1584

9852

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.3

71.5

529

2282

WX308

NOMESCO Finland

Sacral anesthesy

5.0

71.4

153

307

N89

ICPC

Migraine

2.0

71.3

840

4338

SCA02

NOMESCO Finland

Preventive oral health care

1.5

71.2

2638

18390

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

71.1

1740

11088

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

71.0

2145

14338

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

71.0

5269

41292

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

70.9

2647

18479

I702, R262,

ICD-10 Finland

+∞

70.8

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.1

70.5

699

3393

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

70.5

4465

34170

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

70.4

2581

17957

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.9

69.7

323

1106

XP60W, ,

NOMESCO Finland

7.6

69.7

129

R40.2

ICD-10 Finland

Coma, unspecified

3.4

69.7

257

769

R01AD58

ATC

fluticasone, combinations; nasal

1.3

69.6

6107

48967

SPAT1043

SPAT

Audiometry

1.5

69.6

2502

17334

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

69.6

6963

56804

G04CA01

ATC

alfuzosin; oral

1.4

69.5

2834

20118

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.2

69.4

592

2710

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.4

69.1

478

2001

R03AK08

ATC

formoterol and beclometasone; inhalant

1.8

68.9

1094

6212

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

2.4

68.8

473

1975

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

2.3

68.8

515

2233

H29

ICPC

Ear symptom/complaint other

1.4

68.7

2842

20231

H02AB09

ATC

hydrocortisone; systemic

2.2

68.6

622

2917

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

5.1

68.3

143

281

C08CA05

ATC

nifedipine; systemic

1.6

68.0

1506

9364

R31

ICD-10 Finland

Unspecified haematuria

1.5

67.9

2447

16959

G70.0

ICD-10 Finland

Myasthenia gravis

4.9

67.8

147

298

P15

ICPC

Chronic alcohol abuse

2.1

67.8

693

3403

R52.0

ICD-10 Finland

Acute pain

1.9

67.8

836

4385

Y96.9

ICD-10 Finland

Unspecified type of accident

2.4

67.7

491

2099

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

6.2

67.7

116

189

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.3

67.7

261

803

I95.9

ICD-10 Finland

Hypotension, unspecified

2.6

67.7

402

1567

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

67.7

2719

19246

D21

ICPC

Swallowing problem

2.6

67.6

389

1493

Z50.1

ICD-10 Finland

Other physical therapy

1.7

67.5

1307

7847

164

Kela drug reimbursment

Fingolimod

5.8

67.5

123

213

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

7.9

67.4

117

C09CA01

ATC

losartan; oral

1.3

67.4

6258

50528

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.2

67.3

546

2449

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.3

67.3

500

2161

H81.3

ICD-10 Finland

Other peripheral vertigo

2.0

67.2

716

3568

R20.0

ICD-10 Finland

Anaesthesia of skin

3.4

67.2

241

709

S97

ICPC

Chronic ulcer skin

1.6

67.1

1457

9012

K80

ICPC

Cardiac arrhythmia NOS

1.5

67.0

1971

13093

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.2

66.9

590

2737

N07CA01

ATC

betahistine; oral

1.6

66.9

1756

11371

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

66.8

5782

46245

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

66.7

2771

19733

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

66.7

1358

8263

R07.2

ICD-10 Finland

Precordial pain

2.2

66.7

550

2484

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.8

66.5

1014

5690

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

66.4

2625

18518

S06

ICPC

Rash localized

1.7

66.3

1413

8698

M43.1

ICD-10 Finland

Spondylolisthesis

1.8

66.1

979

5444

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.6

66.0

1570

9932

L05

ICPC

Flank/axilla symptom/complaint

1.6

66.0

1458

9057

G40

ICD-10 Finland

Epilepsy

3.2

65.9

267

847

SPAT1251

SPAT

Organisation of medication

1.9

65.8

856

4570

RS222, ,

NOMESCO Finland

2.8

65.7

340

1236

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.7

65.6

1286

7747

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

4.1

65.5

178

432

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

65.5

1698

10962

F32.1

ICD-10 Finland

Moderate depressive episode

1.7

65.4

1398

8613

D07AA02

ATC

hydrocortisone; topical

1.4

65.3

3448

25603

R39.1

ICD-10 Finland

Other difficulties with micturition

2.0

65.1

774

4010

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

2.6

65.0

393

1545

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

2.4

64.9

434

1789

F43.00

ICD-10 Finland

Acute stress reaction mild

2.1

64.9

625

3001

R41.3

ICD-10 Finland

Other amnesia

2.0

64.8

721

3649

AAG20

NOMESCO Finland

Stereotactic intracranial implantation of electrodes

6.4

64.8

107

168

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

64.8

962

5354

N04BB01

ATC

amantadine; oral

2.5

64.8

413

1666

ZY000

NOMESCO Finland

Hospital inpatient

2.7

64.7

347

1286

R03BA02

ATC

budesonide; inhalant

1.3

64.4

4444

34402

XA400

NOMESCO Finland

EEG

3.8

64.3

198

526

DFF15

NOMESCO Finland

Speech audiometry

1.7

64.3

1149

6748

F06.7

ICD-10 Finland

Mild cognitive disorder

2.0

64.3

700

3516

S21

ICPC

Skin texture symptom/complaint

1.4

64.3

3513

26229

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

3.2

64.1

259

820

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

64.0

2197

15074

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

64.0

8477

71413

G40.89

ICD-10 Finland

Other epilepsy

4.4

63.9

160

365

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

63.8

1497

9438

R30.0

ICD-10 Finland

Dysuria

1.8

63.8

1030

5877

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

3.2

63.7

254

798

J01MA12

ATC

levofloxacin; systemic

1.3

63.6

4517

35114

R49.01

ICD-10 Finland

Functional dysphonia

2.0

63.5

729

3730

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.7

63.5

1278

7750

F01

ICPC

Eye pain

2.0

63.5

731

3745

G91.1

ICD-10 Finland

Obstructive hydrocephalus

4.9

63.3

139

285

R32

ICD-10 Finland

Unspecified urinary incontinence

2.0

63.3

687

3448

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.5

63.2

2187

15027

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

63.2

1846

12241

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.0

62.9

650

3205

L18

ICPC

Muscle pain

1.8

62.8

1022

5845

AA400

NOMESCO Finland

Electroconvulsive therapy

3.3

62.8

237

720

R4110

NOMESCO Finland

Physiotherapy

1.3

62.6

6941

57224

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

62.5

6313

51450

PE1AT

NOMESCO Finland

Femoral artery PTA

2.8

62.5

324

1180

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.0

62.4

661

3288

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

62.3

2309

16080

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

62.3

4420

34343

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.3

62.3

478

2095

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.7

62.0

1073

6245

D09

ICPC

Nausea

1.7

62.0

1121

6606

N06AA04

ATC

clomipramine; systemic

2.4

61.8

429

1799

TQW80

NOMESCO Finland

Local dermatologic skincare

2.0

61.8

680

3429

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

2.7

61.8

328

1209

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.8

61.6

958

5406

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

61.4

3054

22436

L99

ICPC

Musculoskeletal disease other

2.2

61.4

542

2517

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

4.4

61.3

153

348

A07AA02

ATC

nystatin; oral

1.6

61.3

1405

8805

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

2.7

61.2

324

1193

R20.8

ICD-10 Finland

Other and unspecified disturbances of skin sensation

2.8

61.1

304

1083

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

3.6

61.1

201

559

PD4CM

NOMESCO Finland

Extensive MRI examination of abdominal aorta and vasculature of lower extremities with 3 Tesla magnet

5.9

61.1

109

185

E87.6

ICD-10 Finland

Hypokalaemia

1.9

61.0

806

4325

N03AB02

ATC

phenytoin; systemic

2.9

60.7

294

1032

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.1

60.7

616

3017

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.7

60.6

1213

7346

A06AC51

ATC

ispaghula, combinations; oral

1.7

60.5

1180

7097

N07XX02

ATC

riluzole; oral

8.2

60.5

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.4

60.4

424

1788

S04

ICPC

Lump/swelling localized

1.4

60.3

2510

17865

F41.8

ICD-10 Finland

Other specified anxiety disorders

1.9

60.2

725

3771

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

60.2

5946

48289

N06AX17

ATC

milnacipran; oral

2.9

60.2

291

1021

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

60.2

5114

40729

B03BA03

ATC

hydroxocobalamin; parenteral

1.6

60.1

1323

8208

E86

ICD-10 Finland

Volume depletion

2.1

59.9

590

2857

T74.1

ICD-10 Finland

Physical abuse

2.3

59.8

457

1999

XF402

NOMESCO Finland

ECG with work load test

1.4

59.7

2487

17701

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

59.7

1821

12184

B01AC07

ATC

dipyridamole; systemic

1.8

59.7

948

5382

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.7

59.5

1134

6777

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

2.5

59.5

365

1446

A08

ICPC

Swelling

1.7

59.5

1206

7328

SPAT1081

SPAT

Cardiorespiratory global assessment

1.6

59.4

1308

8116

A46

ICD-10 Finland

Erysipelas

1.4

59.1

3474

26216

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

3.6

59.1

199

562

XQ800

NOMESCO Finland

Prick test

1.5

59.0

1763

11742

SPAT1281

SPAT

Other administrative function

1.5

59.0

1923

13048

P72

ICPC

Schizophrenia

2.4

59.0

425

1813

E000001, ,

ATC

1.3

59.0

4951

39353

I50.9

ICD-10 Finland

Heart failure, unspecified

1.4

58.9

3170

23589

G83.4

ICD-10 Finland

Cauda equina syndrome

4.4

58.8

149

343

TKC22

NOMESCO Finland

Catheterisation instruction

2.1

58.7

561

2687

H02

ICPC

Hearing complaint

1.4

58.6

3274

24509

C09AA05

ATC

ramipril; oral

1.3

58.5

5975

48700

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

2.9

58.3

269

920

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.2

58.3

527

2470

P25

ICPC

Phase of life problem adult

1.7

58.3

1008

5866

K04.0

ICD-10 Finland

Pulpitis

1.5

58.2

2166

15089

H50.52

ICD-10 Finland

Exophoria

2.7

58.1

312

1157

R4130

NOMESCO Finland

Speech therapy

2.0

57.9

610

3028

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

57.8

5610

45425

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.3

57.7

442

1936

L09

ICPC

Arm symptom/complaint

1.7

57.6

1149

6950

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

4.5

57.6

139

308

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

57.6

2341

16585

J01FA09

ATC

clarithromycin; systemic

1.2

57.5

7839

66085

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

3.2

57.1

226

707

PLAK2, ,

NOMESCO Finland

3.3

57.0

214

648

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

57.0

3231

24234

PEN25

NOMESCO Finland

Plastic repair of superficial femoral artery

4.9

57.0

126

260

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

5.4

56.9

111

205

D07AC13

ATC

mometasone; topical

1.3

56.8

7221

60380

P80

ICPC

Personality disorder

4.1

56.7

157

387

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

56.7

1340

8461

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.6

56.4

1218

7520

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.4

56.3

2502

18011

G97.1

ICD-10 Finland

Other reaction to spinal and lumbar puncture

6.2

56.2

156

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.7

56.2

1028

6077

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

56.1

7340

61563

S00.0

ICD-10 Finland

Superficial injury of scalp

2.1

56.1

566

2767

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.4

55.9

387

1622

AAF00

NOMESCO Finland

Ventriculostomy

3.6

55.8

184

513

SBB10

NOMESCO Finland

Dental impressions

1.5

55.7

1619

10718

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

55.5

9731

84191

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

55.5

3138

23525

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

2.3

55.4

446

1995

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.2

55.2

471

2157

108

Kela drug reimbursment

Myasthenia gravis

5.1

55.2

116

229

G25.1

ICD-10 Finland

Drug-induced tremor

6.1

55.1

156

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.4

55.1

386

1627

SPAT1167

SPAT

Insertion of urinary catheter

1.9

55.0

743

4014

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.9

55.0

741

4000

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.0

54.7

608

3077

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3035350) Ketones [Presence] in Urine by Test strip

16124

126033

1.57

322.08

4.6

3.6

0.00

estimate

0.22

4612

24313

(3002179) Metamyelocytes/100 leukocytes in Blood

3653

18904

2.05

320.89

4.3

3.9

0.61

0.69

0.86

951

6250

(3005719) IgG [Mass/volume] in Serum or Plasma

3594

18524

2.06

319.08

2.7

10.27

10.56

g/l

3.53

3261

16986

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

28442

257664

2.10

315.98

19.6

13.9

20.62

23.91

mg/l

60.85

24069

203347

(3009261) Glucose [Presence] in Urine by Test strip

16214

127418

1.56

312.32

4.6

3.6

0.00

estimate

0.48

4365

22424

(3017181) Myelocytes/100 leukocytes in Blood

3890

20849

1.99

308.99

4.5

4.0

0.91

0.95

0.37

1097

7242

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

8258

55444

1.66

308.48

2.0

1.7

1.04

1.25

mg/l

7.26

6172

42427

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

24057

195716

1.98

307.65

7.9

7.4

77.03

78.69

u/l

6.15

23040

184117

(3036481) Cortisol [Moles/volume] in Serum or Plasma

4438

22555

2.13

307.65

2.2

2.3

360.66

376.25

nmol/l

5.80

4138

20695

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3528

14968

2.53

307.65

1.4

1.3

40.32

52.90

au/ml

2.54

136

770

(3022217) INR in Platelet poor plasma by Coagulation assay

16747

115839

1.95

307.65

14.8

1.22

1.27

inr

7.47

6651

32390

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

1157

1487

8.04

307.65

1.2

1.1

38.69

45.52

mg/l

2.48

964

1254

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

1183

2110

5.78

307.65

1.1

59.65

72.44

au/ml

0.21

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

798

992

8.22

307.65

1.1

1.05

1.09

u/l

0.54

385

429

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

2181

4680

4.93

307.65

1.4

1.3

3.70

3.75

mmol/l

1.05

2059

4397

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3799

16448

2.49

307.65

2.5

2.3

22.33

23.63

au/ml

0.30

215

1301

(3024561) Albumin [Mass/volume] in Serum or Plasma

15341

108896

1.80

307.65

4.9

4.8

35.68

35.49

g/l

3.98

14385

100891

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

8660

52247

1.91

307.65

1.7

37698317.46

31139273.62

pmol/l

0.46

7454

42956

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

15492

114315

1.70

307.65

6.5

6.0

1.21

mmol/l

0.72

14395

104109

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1114

1877

6.11

307.65

1.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

21683

177667

1.71

307.65

5.4

4.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

1122

1423

8.14

307.65

1.1

258.10

271.71

mg/l

0.71

969

1271

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

2243

4633

5.13

307.65

1.5

1660.72

2544.94

e6/l

0.32

1933

3703

(3031040) Bacteria [#/volume] in Urine by Automated count

21310

170066

1.79

307.65

5.9

4.3

1549.12

1433.06

e6/l

0.12

589

2175

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2499

5275

5.06

307.65

1.4

496.41

546.96

mg/l

1.61

2379

5037

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

678

1176

5.87

307.65

1.4

1.5

5.55

5.97

u/l

0.50

558

1005

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

822

1603

5.24

307.65

1.3

1.89

2.16

mmol/l

7.52

768

1490

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6495

40215

1.77

307.65

2.0

1.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

7511

47830

1.75

307.65

4.6

3.6

304.45

501.75

ng/l

4.35

5288

36806

(3022096) Basophils/100 leukocytes in Blood

15574

116659

1.66

307.65

6.7

6.1

0.67

0.74

14793

108569

(3029937) Albumin [Presence] in Urine by Test strip

9890

67302

1.68

307.65

5.0

4.0

0.00

estimate

3.05

4375

22020

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6758

40165

1.87

307.65

3.2

3.5

0.82

mmol/l

0.64

6318

37482

(3021589) Normoblasts [#/volume] in Blood

14802

113308

1.58

307.65

11.6

9.5

0.00

e9/l

1.07

12751

92396

(3006504) Eosinophils/100 leukocytes in Blood

16001

120457

1.67

307.65

6.7

6.1

2.79

2.86

4.17

15227

112418

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

13421

93762

1.75

307.65

4.5

3.5

97.22

59.49

ng/l

0.51

9154

62876

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

605

950

6.47

307.65

1.3

1.2

67.33

63.10

0.31

114

(3019309) Folate [Moles/volume] in Red Blood Cells

7589

46164

1.85

307.65

1.8

1.7

1219.24

1159.26

nmol/l

6.95

6071

34639

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

23724

197851

1.81

307.65

4.7

4.0

14.75

pmol/l

0.04

22178

179749

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

26775

236351

1.90

307.65

5.8

4.7

1.91

2.12

mu/l

1.47

25335

216675

(3002030) Lymphocytes/100 leukocytes in Blood

16310

124683

1.64

307.65

6.8

6.1

27.91

27.97

0.34

15537

116885

(3019069) Monocytes/100 leukocytes in Blood

16065

121162

1.67

307.65

7.0

6.4

8.50

8.54

0.95

15284

113271

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

14190

104948

1.64

307.65

2.5

2.3

77.03

947.50

nmol/l

0.50

13053

94215

(3002582) Erythrocytes [#/volume] in Urine

10951

77078

1.65

307.65

3.9

3.2

78.41

93.41

e6/l

0.49

9008

58545

(3018677) aPTT in Platelet poor plasma by Coagulation assay

6439

38166

1.86

307.65

2.3

2.1

29.66

29.86

1.66

6241

37017

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

936

1121

8.57

307.65

1.5

1.7

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

12094

84483

1.70

307.65

2.8

3.4

2.34

2.35

mmol/l

14.04

10896

73929

(3018010) Neutrophils/100 leukocytes in Blood

16032

122837

1.62

307.65

6.6

5.9

57.24

57.21

0.14

15263

115056

(3023103) Potassium [Moles/volume] in Serum or Plasma

28966

262682

2.33

307.65

21.9

16.0

3.96

mmol/l

0.30

28567

255337

(3006315) Basophils [#/volume] in Blood

17142

128443

1.74

307.65

6.5

5.9

0.04

e9/l

0.78

15374

110811

(3019198) Lymphocytes [#/volume] in Blood

17344

132113

1.70

307.65

6.6

5.9

1.92

1.93

e9/l

0.61

15841

116638

(3026008) Bacteria identified in Urine by Culture

11407

77805

1.73

307.65

3.6

3.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

11969

79355

1.82

307.65

2.9

2.5

56.48

63.46

u/l

3.82

11235

73050

(3019550) Sodium [Moles/volume] in Serum or Plasma

28950

262007

2.35

307.65

21.8

15.8

139.51

139.64

mmol/l

16.39

28581

255172

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1084

1382

8.08

307.65

1.1

—

(3013115) Eosinophils [#/volume] in Blood

17558

132676

1.73

307.65

6.8

6.1

0.19

e9/l

4.01

15933

116059

(3001604) Monocytes [#/volume] in Blood

17087

128139

1.73

307.65

6.5

5.9

0.58

0.59

e9/l

2.12

15337

110647

(3044290) Cell count panel - Cerebral spinal fluid

1958

4418

4.66

307.65

1.4

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

5759

34259

1.83

307.65

1.4

1.3

487.68

542.94

titre

1.41

1173

7087

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

825

1032

8.18

307.65

1.1

2.61

7.33

nmol/l

1.63

151

206

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

14306

73150

2.75

307.65

2.7

2.1

192.03

209.50

u/l

1.53

13651

68356

(3013707) Erythrocyte sedimentation rate by Westergren method

23772

188923

2.06

307.65

4.9

4.0

11.63

12.17

mm/h

7.36

22492

174485

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

17408

131378

1.73

307.65

5.8

6.1

10.64

11.52

umol/l

18.83

16614

124317

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1197

2169

5.69

307.65

1.1

44.08

26.75

au/ml

—

(40760892) CBC W Ordered Manual Differential panel - Blood

16278

120581

1.73

307.65

7.0

6.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

17901

125408

1.99

307.65

7.2

6.7

1.21

mmol/l

0.48

15303

106477

(3013650) Neutrophils [#/volume] in Blood by Automated count

18843

148147

1.68

307.65

9.4

9.0

4.13

4.12

e9/l

0.26

17046

128896

(3013826) Glucose [Moles/volume] in Serum or Plasma

20057

148480

1.97

307.65

5.8

4.6

6.55

6.71

mmol/l

22.08

19263

138279

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

13923

103021

1.63

307.65

2.2

2.0

95.56

96.03

pmol/l

0.55

7645

53735

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

2243

4626

5.14

307.65

1.4

1.5

15.12

30.74

e6/l

1.63

1838

3507

(3021960) Folate [Moles/volume] in Serum or Plasma

8853

57564

1.75

307.65

1.6

1.5

20.01

20.44

nmol/l

1.68

7866

49159

(3000850) Epithelial cells [#/volume] in Urine

8563

53091

1.84

307.65

3.1

2.6

5.69

5.67

e6/l

0.03

7877

47318

(3018418) pH of Serum or Plasma

11096

73940

1.77

307.65

4.2

4.1

7.40

2.87

2660

13639

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

9274

64177

1.63

307.00

2.4

2.3

2.82

2.95

mg/l

6.46

8152

54630

(3044889) 12 lead EKG panel

20963

175013

1.59

306.95

4.3

3.7

—

(3021440) Promyelocytes/100 leukocytes in Blood

3734

19794

2.00

305.83

4.5

4.1

0.11

0.12

0.32

943

6236

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1976

8170

2.51

297.17

2.2

2.3

277.00

567.61

ug/l

7.87

1798

7680

(3025159) Blasts/100 leukocytes in Blood

3562

18758

2.01

296.66

4.5

4.1

0.10

0.36

3.91

779

5261

(3021601) Nitrite [Presence] in Urine by Test strip

15938

126166

1.53

286.75

5.7

4.9

0.00

estimate

0.19

4470

23013

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3696

19948

1.97

286.26

4.0

3.8

1.23

mmol/l

0.72

3321

17318

(3041096) Erythrocytes [Presence] in Urine by Automated

9560

67665

1.59

283.28

4.1

3.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

14544

113141

1.53

281.89

3.2

2.9

119.40

124.59

ug/l

1.32

13602

104782

(3018095) Leukocytes [#/volume] in Urine

12112

90641

1.55

280.00

4.4

3.7

100.74

96.63

e6/l

0.16

9463

63196

(3020630) Protein [Mass/volume] in Serum or Plasma

3659

19881

1.95

277.32

2.2

2.6

66.94

66.36

g/l

4.99

3365

17999

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

12769

96874

1.54

276.06

4.8

3.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

9785

70007

1.58

275.01

3.1

3.0

1278.14

1441.55

ng/l

2.63

8404

59775

(3016018) Differential panel - Cerebral spinal fluid

890

2450

3.71

274.02

1.5

—

(3023368) Bacteria identified in Blood by Culture

9524

67833

1.58

272.38

4.7

4.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

8228

56826

1.61

267.19

1.3

1.33

1.72

u/ml

2.54

2529

14929

(3009466) Valproate [Moles/volume] in Serum or Plasma

1045

3248

3.29

266.61

5.3

4.9

375.55

362.68

umol/l

1.84

938

2770

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

806

2138

3.84

261.79

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

3089

16177

2.01

259.37

2.1

2.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2109

9683

2.26

249.09

1.3

1.2

1.02

0.84

u/ml

0.21

147

886

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

6488

43425

1.62

234.93

1.4

1.3

30.40

36.55

iu/ml

1.92

1901

13852

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10980

82929

1.50

229.95

3.5

3.2

32.37

33.90

u/l

1.08

10414

78530

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3587

20649

1.83

224.22

2.7

2.3

5.76

7.37

ug/l

5.20

3183

17836

(3026782) Osmolality of Urine

7314

50877

1.57

223.25

3.3

2.9

519.45

543.89

mosm/kgh2o

18.40

6452

43487

(3024869) Neuronal Ab [Presence] in Serum

273

304

9.04

222.30

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

271

301

9.07

221.11

1.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

377

610

6.24

220.98

1.3

1.2

20.14

20.57

0.03

102

(3020564) Creatinine [Moles/volume] in Serum or Plasma

29152

271723

2.02

218.88

21.8

16.0

77.43

76.79

umol/l

2.18

29143

271608

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5122

32935

1.66

215.31

5.9

6.0

1.04

1.05

mmol/l

0.28

4832

30602

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2086

10125

2.13

213.47

1.8

2.0

38.90

39.29

u/l

0.40

1892

8931

(3023410) Appearance of Cerebral spinal fluid

778

2344

3.38

208.35

1.6

1.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

6065

40960

1.59

208.12

1.3

7.73

12.64

u/ml

4.61

2614

15535

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6619

45639

1.57

207.64

2.6

3.1

2.44

2.45

mmol/l

8.13

5840

39762

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

25605

230974

1.59

206.75

6.2

5.6

39.75

39.60

mmol/mol

1.75

24152

213406

(40768797) Stomach Pathology biopsy report

5247

34436

1.63

201.98

1.3

1.2

—

(3030467) Casts [#/volume] in Urine by Automated count

9484

71118

1.48

198.49

3.8

3.1

0.37

0.41

e6/l

1.32

7773

53644

(3007164) IgA [Mass/volume] in Serum or Plasma

7027

49526

1.54

198.42

1.5

2.27

2.40

g/l

7.52

4504

29699

(36304419) Bacteria [Presence] in Urine

9266

69209

1.48

197.67

3.7

3.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3460

20429

1.78

197.10

3.2

2.9

186.64

210.15

ng/l

1.63

3125

18633

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

19672

169222

1.43

192.09

3.8

3.0

49.63

47.31

u/l

2.59

18589

157732

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

416

841

5.00

191.76

1.1

152.14

721.45

ng/l

1.75

215

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4345

27657

1.66

187.49

1.9

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4314

27586

1.65

182.41

1.9

1.7

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

520

1348

3.90

174.31

1.0

39.15

43.16

ng/l

0.42

331

950

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

517

1338

3.91

173.70

1.0

276.09

358.57

ng/l

1.89

341

958

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

518

1345

3.90

173.24

1.0

761.61

719.49

ng/l

1.08

324

929

(3011048) Pyruvate [Moles/volume] in Blood

149

15.58

172.43

1.3

77.47

90.64

umol/l

2.19

135

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

306

515

5.99

172.38

1.3

136.67

120.62

nmol/l

0.72

230

369

(3016502) Oxygen saturation in Arterial blood

3941

25020

1.66

170.46

7.5

95.59

95.64

0.19

3796

24072

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

26091

239379

1.53

163.69

17.6

12.9

82.60

81.65

ml/min/173m2

9.49

22545

196714

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

327

617

5.34

163.07

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2342

12976

1.87

162.84

3.1

2.7

0.29

0.28

e6/l

0.15

2287

12644

(3028626) Oxygen [Partial pressure] in Capillary blood

1373

6294

2.23

161.21

3.7

4.1

8.48

8.41

kpa

0.74

1337

6134

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

4469

29651

1.59

160.69

2.0

1.7

1.58

1.44

24.75

3950

26042

(3027801) Oxygen [Partial pressure] in Arterial blood

4260

28072

1.60

157.37

7.3

7.1

12.05

12.48

kpa

6.52

4069

26752

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4262

28092

1.60

157.28

7.3

7.1

5.09

5.08

kpa

0.25

4076

26774

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

28943

272795

1.78

157.04

12.5

10.2

25.87

26.06

u/l

0.94

28269

262996

(3003396) Base excess in Arterial blood by calculation

4253

28119

1.59

154.70

7.3

7.1

1.31

1.00

mmol/l

5.93

3433

22363

(3022948) Iron [Moles/volume] in Serum or Plasma

5742

40649

1.50

153.01

2.6

2.5

13.05

13.08

umol/l

0.11

5323

37835

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

26533

245170

1.53

152.03

4.9

4.5

5.95

5.91

mmol/l

3.90

24740

223794

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2596

15148

1.78

151.84

7.6

7.0

24.90

24.52

mmol/l

6.21

2488

14408

(3015736) pH of Urine

12551

102426

1.37

151.51

4.1

3.3

5.88

0.01

784

7672

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1328

6177

2.20

150.27

3.2

3.3

24.92

24.63

mmol/l

1.77

1296

6039

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2977

18212

1.70

146.88

1.7

1.6

—

(3019150) Specific gravity of Urine by Refractometry

7366

55113

1.44

146.82

5.0

3.9

1.02

kg/l

0.15

1060

8504

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1663

8554

2.00

143.90

2.0

2.3

2.73

2.97

g/l

20.84

1513

7583

(3021901) Oxygen saturation in Capillary blood

1042

4472

2.37

142.62

2.8

2.9

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

14455

121381

1.35

142.02

2.8

2.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1740

9136

1.96

141.84

2.0

2.3

7.20

7.43

g/l

7.45

1586

8165

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1737

9126

1.96

141.33

2.0

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1734

9111

1.95

141.04

2.0

2.3

3.51

3.75

g/l

10.68

1584

8146

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1505

7536

2.05

140.31

1.8

1.7

0.23

g/l

0.62

1435

7133

(3047181) Lactate [Moles/volume] in Blood

1523

7669

2.03

139.80

5.4

5.8

1.31

1.30

mmol/l

0.17

1370

6789

(3004789) Transferrin [Mass/volume] in Serum or Plasma

5293

37474

1.50

139.38

2.6

2.5

2.36

2.34

g/l

1.95

4889

34624

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1534

7763

2.02

138.86

1.8

1.6

1.17

1.18

g/l

0.48

1470

7372

(3019060) Gas panel - Arterial blood

2665

16065

1.72

138.38

5.1

4.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1640

8510

1.98

138.27

2.0

2.3

9.57

10.24

g/l

9.95

1479

7486

(3048689) Calprotectin [Mass/mass] in Stool

4575

31477

1.53

137.98

2.3

126.65

132.65

ug/g

0.52

3613

24664

(3023183) Ammonium ion [Moles/volume] in Plasma

1128

5097

2.26

136.85

3.0

2.6

31.33

33.77

umol/l

3.40

1049

4575

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3538

23096

1.60

134.32

8.1

7.9

123.19

121.03

g/l

8.24

3449

22473

(3007853) Bacteria identified in Skin by Aerobe culture

4408

30303

1.53

132.99

2.0

1.8

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

446

1264

3.56

131.26

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1584

8392

1.93

125.40

1.7

1.6

282.99

252.89

titre

0.17

362

(3012544) pH of Venous blood

3648

24387

1.56

124.29

4.6

4.1

7.39

7.38

0.90

172

(3002385) Erythrocyte distribution width [Ratio]

24318

223212

1.39

123.51

22.2

16.4

14.82

15.02

2.72

24041

219195

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

371

967

3.87

123.45

1.4

2.1

29.84

28.44

umol/l

1.82

362

933

(3013247) Albumin in CSF/Albumin in Serum or Plasma

240

450

5.36

120.60

1.1

6.86

7.02

mg/g

0.11

223

432

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1723

9503

1.86

120.43

2.1

1.8

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1894

10772

1.81

119.79

1.5

10.48

14.60

u/ml

0.76

279

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

4893

35051

1.47

119.38

2.7

2.6

22.64

22.56

0.16

4077

29991

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1836

10404

1.81

117.48

2.2

2.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1444

7641

1.93

114.54

2.0

1.7

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

419

1252

3.38

113.63

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

228

431

5.32

113.56

1.3

1.2

—

(3002032) Base excess in Venous blood by calculation

3484

23552

1.54

112.05

4.7

4.1

1.96

1.84

mmol/l

1.28

2973

19995

(3045716) Anion gap in Serum or Plasma

358

974

3.70

112.01

2.7

2.4

9.49

9.94

mmol/l

1.38

346

944

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3488

23621

1.54

111.21

4.6

4.1

5.91

5.82

kpa

5.84

3390

22948

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

22.54

111.03

1.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3663

25251

1.51

107.14

4.1

3.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

2353

14711

1.65

105.17

1.9

1.29

1.33

g/l

0.37

2169

13395

(3009542) Hematocrit [Volume Fraction] of Blood

29744

286240

1.74

100.66

28.5

20.5

40.28

40.20

0.20

27824

268371

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

181

313

5.81

99.27

1.1

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2504

16132

1.60

98.78

3.0

3.4

4.44

4.48

pmol/l

1.34

2229

14374

(3010421) pH of Blood

1237

6528

1.93

98.69

4.4

3.9

7.42

1.69

1160

5931

(3009508) Creatinine [Moles/volume] in Urine

9596

78774

1.31

98.35

3.4

3.2

7.50

7.54

mmol/l

0.32

8256

66396

(1616796) Gas panel - Central venous blood

1102

5597

2.00

98.27

3.9

3.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1695

9878

1.76

98.15

2.7

2.2

4559.76

5702.05

u/l

0.87

581

3880

(3007461) Platelets [#/volume] in Blood

29746

286470

1.72

97.61

28.4

20.4

252.96

252.10

e9/l

1.46

29332

278702

(3027945) Reticulocytes/100 erythrocytes in Blood

3987

28438

1.46

97.59

2.7

2.6

1.77

1.75

0.25

3574

25073

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1409

7784

1.85

97.56

2.2

2.4

0.63

0.94

g/l

3.52

1232

6605

(3018405) Lactate [Moles/volume] in Arterial blood

1502

8466

1.81

97.42

4.5

4.1

1.35

1.39

mmol/l

0.54

1471

8313

(3020779) Urea [Moles/volume] in Serum or Plasma

3276

22490

1.51

97.08

7.6

7.4

9.26

9.85

mmol/l

5.11

3127

21371

(3027315) Oxygen [Partial pressure] in Blood

1109

5702

1.98

95.47

4.6

4.0

8.75

8.61

kpa

1.95

1094

5557

(3005322) IgE [Units/volume] in Serum or Plasma

2477

16041

1.59

95.46

1.4

1.3

200.70

242.77

u/ml

1.36

2292

14843

(3035941) MCH [Entitic mass]

29749

286655

1.71

95.42

28.2

20.3

30.32

30.26

7.04

29523

282481

(3024731) MCV [Entitic volume]

29750

286687

1.71

95.13

28.2

20.3

91.14

90.87

20.43

29522

282510

(3012501) Base excess in Blood by calculation

1103

5668

1.98

95.10

4.5

3.9

2.40

2.51

mmol/l

0.69

773

3804

(3013290) Carbon dioxide [Partial pressure] in Blood

1103

5670

1.98

95.01

4.5

4.0

5.05

4.98

kpa

2.46

1088

5526

(3026361) Erythrocytes [#/volume] in Blood

29751

286711

1.71

94.96

28.3

20.4

4.46

4.49

e12/l

14.74

29283

278068

(3010813) Leukocytes [#/volume] in Blood

29752

286731

1.71

94.84

28.4

20.4

6.86

6.74

e9/l

12.92

29291

278070

(3024666) Lithium [Moles/volume] in Serum or Plasma

398

1292

3.11

94.22

11.9

12.1

0.63

0.62

mmol/l

0.17

366

1186

(3000963) Hemoglobin [Mass/volume] in Blood

29753

286789

1.71

94.17

28.5

20.5

134.36

134.96

g/l

10.49

29522

282651

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2515

16435

1.58

93.13

3.8

4.0

5.18

5.13

kpa

2.72

2395

15530

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1264

6847

1.88

93.06

2.0

2.3

0.02

0.03

g/l

0.93

1164

6211

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

820

3806

2.18

92.90

1.5

1.4

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

14.34

91.87

1.1

0.56

0.06

mg/l

0.47

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2430

15825

1.58

91.25

7.6

7.3

24.76

mmol/l

0.03

2413

15677

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1294

7106

1.86

91.24

2.0

2.2

38.79

37.51

g/l

11.96

1141

6117

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

386

1257

3.09

90.90

1.5

1.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

749

3381

2.24

90.87

1.3

0.24

0.25

nmol/l

0.09

222

(3033658) Prothrombin time (PT) actual/Normal

8060

65152

1.32

90.69

4.6

4.0

90.22

90.03

0.28

7812

63545

(3025941) Bacteria identified in Stool by Culture

2273

14599

1.60

90.51

1.3

1.2

—

(40761511) CBC panel - Blood by Automated count

28123

268006

1.47

89.63

17.9

13.1

—

(3009343) pH of Capillary blood

2471

16248

1.56

88.87

3.8

4.0

7.42

0.08

419

1980

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

744

3383

2.23

88.68

1.3

0.60

1.50

nmol/l

1.22

713

3248

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3991

28948

1.43

88.57

3.5

4.2

238.30

244.11

u/l

1.35

3768

27357

(3028707) Methadone [Presence] in Urine by Screen method

844

4043

2.12

88.18

3.3

2.6

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

951

4783

2.02

87.09

1.3

1.2

71.67

154.34

titre

1.33

(3014111) Lactate [Moles/volume] in Serum or Plasma

3166

22047

1.48

86.88

7.3

6.9

1.35

1.36

mmol/l

0.09

3085

21480

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

234

581

4.05

83.43

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

198

434

4.58

83.00

1.1

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

681

3072

2.24

82.75

1.3

—

(40767503) Oxygen content in Capillary blood by calculation

1014

5316

1.94

82.37

2.8

2.5

16.77

16.35

2.47

547

2750

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

221

539

4.12

80.73

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

231

584

3.98

80.36

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1154

6360

1.84

80.32

2.1

2.3

0.00

g/l

0.32

1057

5747

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1648

10056

1.67

80.31

5.3

5.0

1.73

1.66

1.35

1549

9432

(3007930) Methemoglobin/Hemoglobin.total in Blood

1624

9878

1.68

80.10

5.3

5.0

0.88

0.89

0.56

1530

9264

(3012516) Albumin [Mass/volume] in Urine

8796

72893

1.29

79.89

3.4

3.3

871.35

391.60

mg/l

9.01

5997

46233

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1229

6925

1.81

79.56

1.3

27.52

39.68

u/ml

1.30

398

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1138

6265

1.85

79.48

2.1

2.3

0.00

g/l

-0.00

1054

5729

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

102

9.23

78.14

1.0

—

(3011412) CD3 cells [#/volume] in Blood

560

2385

2.37

77.87

2.8

2.4

1.35

1.16

e9/l

4.38

510

2113

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

967

5093

1.93

77.45

1.3

1.2

34.85

44.54

u/ml

1.24

107

492

(3042936) Bacteria identified in Isolate by Culture

4707

35869

1.37

77.06

2.1

2.0

—

(3000991) Gas panel - Venous blood

3049

21552

1.46

76.95

8.5

8.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

483

1941

2.51

76.28

1.9

1.4

1.26

1.35

promille

0.62

370

1467

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

468

1855

2.54

76.08

2.7

2.0

13.92

15.06

1.70

462

1802

(40761536) Microorganisms panel - Urine sediment

3075

21823

1.45

75.92

5.2

3.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

333

1108

3.03

75.62

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

473

1890

2.52

75.61

2.7

2.1

74.44

71.76

3.65

463

1809

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2338

15762

1.52

74.51

3.7

4.0

1.97

1.64

mmol/l

4.28

1695

11624

(3021387) Prolactin [Units/volume] in Serum or Plasma

1470

8890

1.68

73.99

1.7

1.6

317.76

311.91

mu/l

0.20

1351

8022

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

226

598

3.80

73.77

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2710

18875

1.48

73.62

3.7

4.0

88.59

90.81

ng/l

0.56

2331

16323

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1253

7275

1.75

73.15

1.8

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

8065

66724

1.28

72.75

2.8

2.6

2327.85

4529.34

umol/l

8.67

7051

58293

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

223

591

3.79

72.64

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1890

12245

1.58

71.99

1.1

117.12

226.72

titre

2.13

318

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

269

814

3.32

71.65

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

443

1762

2.53

71.52

2.8

2.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

142

268

5.31

70.99

2.2

2.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

316

1060

3.00

70.78

2.1

2.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

486

2032

2.41

70.46

2.1

2.4

19.29

19.06

nmol/l

0.20

464

1922

(3028271) Lactate [Moles/volume] in Capillary blood

783

3969

2.00

70.10

2.3

1.8

1.70

1.72

mmol/l

0.23

767

3875

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1243

7297

1.73

69.74

1.5

1.4

290.36

271.74

ug/g

2.38

749

4193

(3040151) Glucose [Moles/volume] in Capillary blood

613

2858

2.17

68.67

18.5

6.7

7.38

7.37

mmol/l

0.02

508

2328

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1119

6404

1.77

68.63

1.3

7.50

8.00

u/ml

0.09

161

1010

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1105

6312

1.78

68.21

1.3

4.87

6.76

u/ml

0.54

109

652

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

307

1035

2.98

68.17

2.3

2.0

143.45

128.97

umol/l

0.32

147

547

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

947

5170

1.86

67.86

1.3

1.2

27.77

11.81

u/ml

—

(3043409) Potassium [Moles/volume] in Arterial blood

1239

7324

1.72

67.78

5.0

4.4

3.86

3.88

mmol/l

1.09

1231

7261

(3003181) Sodium [Moles/volume] in Urine

802

4149

1.96

67.71

1.5

1.4

63.50

63.15

mmol/l

0.08

656

3284

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2005

13341

1.54

67.69

9.8

9.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

434

1758

2.49

67.43

1.1

283.16

292.66

mg/l

1.91

415

1557

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2263

15514

1.49

66.25

9.1

8.9

1.41

1.37

1.10

2246

15409

(3013637) Mi-2 Ab [Presence] in Serum

201

534

3.78

65.29

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

201

534

3.78

65.29

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

201

534

3.78

65.29

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

201

534

3.78

65.29

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3854

29160

1.37

64.98

2.7

2.8

7.12

8.63

umol/l

4.82

3245

25199

(3008295) Osmolality of Serum or Plasma

523

2342

2.25

64.74

1.4

1.5

280.89

278.88

mosm/kgh2o

1.08

410

1807

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2252

15497

1.49

64.65

9.2

9.0

0.69

0.67

0.87

2238

15400

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

294

998

2.96

64.52

2.6

2.3

57.15

51.48

umol/l

2.16

255

849

(3035637) Corticotropin [Mass/volume] in Plasma

647

3163

2.07

64.04

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

25328

239838

1.29

63.84

4.2

3.9

1.34

1.28

mmol/l

34.39

23627

219800

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1880

12538

1.53

62.67

5.8

4.5

24.12

24.08

mmol/l

0.23

1843

12263

(44816559) Phosphatidylethanol [Mass/volume] in Blood

837

4508

1.88

62.58

1.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3210

23727

1.39

62.31

2.2

2.3

0.22

0.21

g/l

2.74

2983

22030

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2167

14910

1.49

62.16

1.6

1.5

—

(3013512) EKG study

8542

72323

1.25

61.01

4.2

3.9

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

26693

254845

1.31

60.95

5.2

4.8

2.68

2.76

mmol/l

39.33

25003

235362

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

126

246

5.14

60.70

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

893

4960

1.82

60.51

1.6

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

26271

250327

1.30

60.50

4.8

4.3

4.56

4.66

mmol/l

49.09

24674

232347

(3019225) pH of Specimen

3330

24894

1.38

60.21

4.1

4.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

2709

19557

1.42

60.17

4.2

3.5

4.65

4.60

kpa

0.57

2624

18917

(3020682) Albumin/Creatinine [Ratio] in Urine

9011

76835

1.24

60.17

3.9

3.8

9.78

9.56

mg/mmol

0.13

5897

48371

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

665

3375

1.99

59.35

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

123

240

5.14

59.30

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1002

5811

1.75

58.63

2.3

2.2

131.41

129.35

g/l

1.96

819

4172

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1172

7108

1.67

58.19

1.3

—

(3022806) Fractional oxyhemoglobin in Capillary blood

635

3202

2.00

57.72

2.1

1.8

90.23

89.67

1.77

626

3154

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1106

6623

1.69

57.61

1.9

2.0

9.23

11.26

mg/l

14.64

1033

6142

(3001186) Copper [Moles/volume] in Serum or Plasma

195

554

3.53

57.42

1.2

1.3

16.54

17.14

umol/l

0.86

182

492

(3014007) Fractional oxyhemoglobin in Arterial blood

2216

15572

1.45

56.89

9.4

9.0

93.84

93.90

0.16

2202

15521

(3039000) Anion gap in Blood

941

5408

1.76

56.83

6.8

6.7

11.04

11.21

mmol/l

0.89

864

4870

(3018572) Chloride [Moles/volume] in Blood

941

5409

1.76

56.80

6.8

6.7

104.79

105.15

mmol/l

1.40

864

4871

(3000494) Fungus identified in Specimen by Culture

3833

29530

1.34

56.78

1.5

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

26048

248364

1.28

56.63

4.7

4.3

1.43

1.47

mmol/l

48.64

24439

229344

(3011985) Renin [Units/volume] in Plasma

642

3276

1.98

56.42

1.5

62.96

63.70

mu/l

0.03

584

2903

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2443

17548

1.42

55.63

1.2

125.57

144.12

iu/ml

1.46

918

6536

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

600

3022

2.00

54.73

1.3

1.4

281.86

404.11

pmol/l

1.79

534

2600

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

290

1069

2.73

54.69

1.1

1696.35

1495.63

miu/ml

1.98

290

1069

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1589

10525

1.54

54.50

1.1

2.38

8.29

u/ml

0.98

140

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

346

1399

2.49

54.06

16.4

17.5

1417.37

2626.44

nmol/l

0.80

329

1336

(1001926) Buprenorphine [Presence] in Urine by Screen method

1188

7379

1.63

53.69

2.9

2.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

18130

166833

1.20

53.47

3.3

3.0

—

(3022145) Colonoscopy Study observation

3682

28430

1.33

53.47

1.3

—

(40768804) Tissue Pathology biopsy report

11839

104710

1.21

53.40

2.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

809

4560

1.79

52.21

3.5

3.2

—

(3023520) Reticulocytes [#/volume] in Blood

2845

21211

1.37

51.85

2.4

2.6

70.23

69.22

e9/l

0.77

2161

15988

(3020891) Body temperature

1481

9774

1.54

51.61

5.5

4.8

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1216

7684

1.61

51.20

1.7

1.6

0.24

7.70

iu/ml

2.04

202

1719

(3011288) Drugs identified in Urine by Screen method

1054

6444

1.66

50.69

3.9

2.8

—

(36660697) Celiac disease serology panel - Serum

2777

20703

1.37

50.56

1.2

—

(3036180) Methadone [Presence] in Urine

289

1111

2.61

50.20

3.4

2.1

—

(3022621) pH of Urine by Test strip

2297

16626

1.41

49.88

3.2

2.9

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

100

190

5.27

49.74

1.0

1.1

—

(3019977) pH of Arterial blood

322

1321

2.45

48.82

2.5

7.42

0.04

476

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

888

5244

1.71

48.68

1.3

1.2

6.93

5.14

u/ml

0.20

394

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1463

9782

1.52

47.94

2.1

2.0

2.60

2.09

ug/l

0.61

1274

8611

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

321

1332

2.42

47.48

12.3

12.6

764.09

836.42

nmol/l

1.94

303

1286

(3037756) Immunofixation for Serum or Plasma

856

5064

1.71

46.63

1.5

1.7

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

386

1753

2.22

46.30

2.9

2.6

562.76

506.19

e6/l

1.46

328

1451

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1078

6795

1.61

45.84

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

547

2841

1.94

45.72

1.4

1.8

4160.00

2792.52

titre

—

107

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

283

1131

2.51

45.42

1.1

10.79

13.12

u/ml

0.13

121

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

221

782

2.84

45.14

1.1

—

(4062490) Immunoglobulin typing, IgG

502

2552

1.98

44.67

1.6

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3401

26592

1.31

44.61

2.1

2.0

—

(3016879) Cocaine [Presence] in Urine

1331

8897

1.52

43.62

2.8

2.0

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1154

7481

1.56

43.51

3.0

3.3

5.69

4.03

ratio

0.18

133

555

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

371

1701

2.19

43.50

3.0

2.6

0.24

0.23

e9/l

0.30

324

1452

(3051339) Copper [Moles/volume] in Blood

101

6.74

43.49

1.2

16.94

16.83

umol/l

0.06

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

523

2722

1.94

43.47

1.1

1.60

2.31

iu/ml

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1182

7706

1.55

43.46

3.0

3.3

34.81

44.21

mg/l

2.07

953

6235

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2048

14879

1.40

43.33

1.8

1.7

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

498

2553

1.96

43.27

1.6

1.4

0.38

0.41

g/l

1.18

362

1799

(3028192) IgG subclass 2 [Mass/volume] in Serum

498

2554

1.96

43.22

1.6

1.4

2.78

2.94

g/l

1.12

360

1798

(3027135) IgG subclass 1 [Mass/volume] in Serum

498

2555

1.96

43.18

1.6

1.4

6.29

6.87

g/l

3.50

361

1798

(3007916) DNA double strand Ab [Titer] in Serum

117

285

4.11

43.03

1.3

56.67

163.78

titre

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1182

7724

1.55

43.00

3.0

3.3

76.88

61.77

mg/l

0.23

951

6252

(3003327) Ova and parasites identified in Stool by Light microscopy

1306

8724

1.52

42.93

1.7

—

(3008898) HLA-B27 [Presence]

1277

8490

1.52

42.93

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

240

912

2.64

42.75

2.3

2.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1128

7307

1.56

42.67

1.5

1.4

10.99

10.30

u/l

0.87

940

5907

(3036489) Thrombin time

1416

9632

1.49

42.64

2.2

21.35

21.61

0.59

1170

8453

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

16.37

42.61

1.0

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

5655

47275

1.24

42.61

1.9

—

(3017569) Oxygen content in Arterial blood

261

1038

2.53

42.36

2.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

138

383

3.61

42.23

1.5

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1609

22599

0.70

42.18

1.6

1.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1689

11922

1.44

42.00

3.7

3.5

25.46

25.18

mmol/l

2.83

1632

11585

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

330

1466

2.26

41.81

1.2

1.1

1.06

1.07

ratio

0.37

135

504

(3028717) Thiamine [Mass/volume] in Blood

100

221

4.53

41.71

1.1

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

929

5779

1.63

41.70

2.9

3.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

701

4048

1.75

41.67

1.6

0.66

0.77

g/l

1.96

527

3081

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

119

6.06

41.54

1.0

1.1

2.58

3.33

u/l

0.26

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

444

2223

2.01

41.29

1.3

8.34

8.42

mmol/l

0.16

436

2124

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1081

7025

1.56

40.31

1.5

16.50

14.28

iu/ml

0.16

168

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

151

5.31

40.15

1.5

1.4

37.51

38.35

0.05

106

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

267

1103

2.43

39.97

3.9

—

(3000764) Benzodiazepines [Presence] in Urine

1397

9603

1.48

39.89

2.8

1.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

7005

60225

1.21

39.60

4.4

3.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

3699

29676

1.28

39.49

1.7

1.6

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

220

836

2.64

39.24

2.9

28.47

28.70

umol/l

0.10

162

639

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

882

5502

1.62

39.15

1.3

1.4

—

(21494755) Public health laboratory ask at order entry panel

1799

24496

0.72

39.14

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

569

3152

1.82

38.98

1.3

1.2

42.41

56.22

u/ml

0.74

216

(4200892) Spirometry reversibility

2416

18331

1.34

38.82

1.5

1.4

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

118

313

3.78

38.62

1.4

1.3

42.98

52.54

1.17

146

(3026389) Candida sp identified in Specimen by Organism specific culture

641

3694

1.75

38.41

1.5

1.3

—

(3028300) Cannabinoids [Presence] in Urine

1398

9688

1.46

38.28

2.8

1.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1704

12281

1.41

37.65

1.4

27.25

27.69

iu/l

0.21

1483

10539

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

7042

60850

1.20

37.35

4.4

4.3

22.05

22.04

0.03

3128

30039

(3027008) Opiates [Presence] in Urine

1388

9669

1.45

36.98

2.6

1.9

—

(3006245) CD3-CD19+ cells/100 cells in Blood

243

1003

2.43

36.50

3.0

2.3

9.49

11.73

2.01

227

937

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

240

985

2.45

36.50

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

329

1553

2.13

35.93

1.2

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

154

507

3.05

35.91

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

195

732

2.67

35.69

2.4

1.9

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

208

808

2.58

35.54

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5249

44316

1.22

35.10

3.3

2.8

1.05

1.20

e6/l

1.01

3091

25140

(3044640) Blood type and Crossmatch panel - Blood

9260

82384

1.17

34.49

2.7

2.4

—

(3027944) Amphetamines [Presence] in Urine

1354

9520

1.44

34.31

2.7

1.9

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

234

978

2.40

34.23

3.1

2.1

28.51

28.62

0.04

228

927

(3049717) Cytology report of Urine Cyto stain

1346

9469

1.44

34.00

2.4

2.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

191

729

2.63

33.85

2.7

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

191

729

2.63

33.85

2.7

2.4

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

134

5.16

33.60

1.6

1.5

12.11

14.02

0.23

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2292

17643

1.32

33.17

2.5

2.1

11.81

11.95

nmol/l

0.34

2033

15699

(3033942) Copper [Moles/time] in 24 hour Urine

6.43

33.11

1.1

1.3

0.25

0.92

umol/24h

1.35

(3014148) Varicella zoster virus Ab [Titer] in Serum

555

3209

1.74

32.93

1.1

1.2

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

112

5.54

32.68

1.3

2.14

1.34

0.42

(3051387) C reactive protein [Mass/volume] in Capillary blood

835

5378

1.57

32.42

4.1

3.3

23.82

27.30

mg/l

2.17

569

3386

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2495

31566

0.77

32.24

4.6

4.4

32.15

32.57

1.19

1808

21841

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

5576

47700

1.20

32.21

1.7

1.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

247

3.85

32.07

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

211

868

2.44

32.00

1.3

1.2

0.31

g/l

0.84

165

698

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

148

4.80

31.88

1.0

1.1

8.52

9.45

u/l

0.17

148

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

199

800

2.50

31.72

1.3

1.2

112.21

111.65

0.10

180

714

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2574

20255

1.29

31.61

2.6

2.7

69.40

65.46

ml/min/173m2

5.42

1116

8003

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3802

31350

1.24

31.54

9.1

6.8

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

858

5601

1.55

31.38

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

858

5602

1.55

31.36

1.4

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1071

7333

1.48

31.18

1.4

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3604

29578

1.25

31.17

2.2

2.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1972

14997

1.34

30.99

4.2

3.5

129.48

128.74

g/l

0.79

1915

14663

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1052

15117

0.68

30.97

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4868

41297

1.21

30.51

3.5

2.9

3.23

2.87

e6/l

1.38

2731

22298

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

142

498

2.86

29.68

2.9

6.3

71.93

69.32

0.58

123

391

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

245

1112

2.21

29.64

1.6

3.51

10.33

nmol/l

0.72

200

935

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

142

4.72

29.52

1.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

695

4408

1.59

28.87

1.9

1.8

4.91

5.13

mmol/24h

0.63

629

3874

(3023419) Bacteria identified in Sputum by Culture

598

3661

1.64

28.72

2.6

2.5

—

(3000060) B lymphocytes [#/volume] in Blood

185

757

2.45

28.45

3.2

2.2

163.54

464.98

e6/l

2.04

426

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

233

1059

2.21

28.12

1.1

98.18

96.28

0.38

194

828

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

110

5.19

28.00

1.1

1.4

—

21331.78

—

(3052851) Hemolysis interference index of Serum or Plasma

1114

7852

1.43

27.85

3.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

884

5964

1.50

27.72

1.5

1.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1553

11590

1.36

27.63

1.6

1.7

1.56

1.53

g/l

0.90

1342

9879

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

376

6647

0.56

27.40

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

377

6652

0.56

27.29

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

376

6635

0.56

27.23

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

1071

7534

1.44

27.07

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1069

7518

1.44

27.06

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

375

6602

0.56

26.93

1.4

—

(3022313) Gas panel - Capillary blood

1592

11974

1.35

26.90

4.1

4.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

146

548

2.67

26.87

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

325

1699

1.92

26.87

1.2

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

122

419

2.92

26.55

1.1

1.4

18.75

195.66

titre

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

326

1714

1.91

26.50

1.2

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

311

1615

1.93

26.24

2.1

3.4

82.42

140.83

nmol/l

6.35

305

1591

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

591

3691

1.61

26.23

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1056

7457

1.43

26.14

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1725

13191

1.32

26.02

9.5

9.1

24.29

24.30

mmol/l

0.05

1665

12725

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2910

23776

1.25

25.93

2.8

2.5

46.58

44.35

u/l

0.09

2480

20343

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

8538

76787

1.15

25.79

4.8

5.0

2.82

3.44

ug/l

0.74

7717

68651

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

571

3557

1.62

25.62

1.1

119.59

117.73

0.69

506

3205

(3013139) Helicobacter pylori Ag [Presence] in Stool

2166

17119

1.28

25.54

1.2

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

515

3130

1.66

25.50

1.9

2.2

32.79

32.54

0.67

508

3107

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

183

786

2.33

25.33

2.2

2.4

136.73

151.12

nmol/l

0.86

164

682

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

136

4.49

25.31

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

139

527

2.64

25.11

1.1

—

(40761535) Cells panel - Urine sediment

2591

20971

1.26

25.06

4.0

3.4

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

293

3.25

24.88

3.1

39.78

41.60

umol/l

0.35

248

(3024928) Oxygen saturation in Venous blood

777

5226

1.50

24.77

4.8

3.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

7044

62661

1.16

24.47

2.6

2.3

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

552

3457

1.61

24.26

1.6

2.0

7.00

7.56

titre

0.04

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

600

3839

1.57

24.08

1.3

1.2

3.53

3.65

u/ml

0.06

206

1344

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

427

7050

0.60

24.02

1.4

1.5

—

(40758558) Short blood count panel - Blood

7362

65817

1.15

23.77

6.8

7.0

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

244

1206

2.03

23.77

1.8

1.9

144.13

143.83

0.02

233

1123

(3020717) Zinc [Moles/volume] in Serum or Plasma

248

1233

2.02

23.77

1.4

1.5

24.11

24.72

umol/l

0.11

240

1177

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

142

4.23

23.11

1.0

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1111

8087

1.39

23.11

2.5

2.6

94.60

91.71

4.07

1050

7760

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1519

11632

1.32

22.67

4.0

3.0

1.41

1.25

5.79

1511

11571

(3048929) Epstein Barr virus Ab [Presence] in Serum

1112

8133

1.38

22.47

1.3

—

(3045414) Leukocytes [Presence] in Urine

1494

11437

1.32

22.35

2.0

1.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

230

1139

2.03

22.32

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

328

1827

1.80

22.30

1.3

2.02

1.90

u/ml

0.06

181

1043

(3044927) Protein electrophoresis panel - Urine

406

2407

1.69

22.17

1.1

1.2

—

(3042517) Benzodiazepines panel - Urine

260

3.23

21.93

3.5

2.5

—

(3016038) Potassium [Moles/volume] in Urine

293

1585

1.86

21.91

1.5

1.3

33.28

34.79

mmol/l

0.49

256

1344

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1737

13613

1.29

21.83

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

341

1934

1.77

21.82

1.4

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

251

3.27

21.80

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

253

1307

1.94

21.78

1.5

9.84

8.05

ug/l

0.44

230

1184

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

257

3.23

21.66

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

317

5500

0.57

21.65

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1723

13514

1.29

21.52

2.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

316

2.98

21.35

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

180

827

2.18

21.30

1.1

95.26

89.46

1.20

102

371

(3005033) Fetal Nuchal fold Thickness US

308

5359

0.57

21.27

1.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1065

7810

1.38

21.19

3.1

2.7

3.57

g/l

0.05

1014

7431

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2113

17027

1.26

21.14

2.0

1.9

—

(3004616) Nuclear Ab [Presence] in Serum

488

3076

1.59

20.95

1.3

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

338

1940

1.75

20.78

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

338

1941

1.75

20.75

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

127

507

2.51

20.74

1.1

0.72

0.78

umol/24h

0.17

240

(3047352) Trisomy 18 risk [Likelihood] in Fetus

311

5360

0.58

20.74

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

338

1944

1.75

20.64

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1021

7470

1.38

20.61

2.7

2.6

178.48

188.35

3.19

948

7074

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

198

958

2.07

20.52

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

600

3982

1.52

20.47

1.2

—

(3004451) EKG impression Narrative

228

1164

1.96

20.36

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

335

1930

1.74

20.34

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

221

1117

1.98

20.31

1.2

149.86

159.30

mmol/24h

1.08

221

1117

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

569

3741

1.53

20.29

1.3

1.2

3.99

3.84

u/ml

0.13

242

1686

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

258

1377

1.88

20.17

1.9

1.8

1.81

2.62

u/field

1.54

161

978

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1135

8474

1.35

20.15

3.6

3.3

0.36

0.35

u/ml

0.20

672

4820

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

334

1930

1.74

20.08

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

333

1927

1.73

19.92

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

219

1112

1.98

19.88

1.7

2.1

1.94

umol/l

0.02

204

1048

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

280

1543

1.82

19.79

2.3

99.59

97.35

0.50

260

1444

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

7299

65898

1.14

19.76

1.7

1.6

1.45

1.35

mmol/l

11.81

6112

55456

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

143

3.92

19.54

1.1

1.2

—

(3000492) Spirometry study

2942

24745

1.21

19.53

1.5

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

181

863

2.10

19.53

1.1

1.2

117.20

106.67

2.69

165

783

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

521

3402

1.54

19.20

1.5

—

(3037121) Protein [Mass/volume] in Urine

1176

8894

1.33

19.16

2.8

3.3

0.31

0.33

g/l

0.20

450

4004

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

163

752

2.17

19.15

1.2

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1426

11081

1.30

19.12

4.3

4.0

46.67

48.41

1.77

1409

10956

(3042631) Mycobacterium sp identified in Specimen

511

3326

1.54

19.11

2.7

2.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

178

852

2.09

19.03

1.1

91.47

90.19

0.24

100

378

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

659

4536

1.46

18.81

2.1

1.8

185.37

191.59

pmol/l

0.70

618

4279

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

572

3835

1.50

18.64

1.1

810.31

3262.51

iu/ml

0.42

162

822

(3000012) Reticulocyte production index

530

3497

1.52

18.64

2.0

2.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

325

2.80

18.59

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1689

13484

1.27

18.27

1.9

1.8

—

(3032773) Endomysium IgG Ab [Titer] in Serum

367

2235

1.65

18.19

1.1

—

61.25

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

178

867

2.06

18.19

1.4

14.03

15.19

pmol/l

2.39

152

726

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

876

6393

1.38

18.00

1.9

1.8

13.86

13.99

iu/l

0.00

314

2359

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

805

5802

1.40

17.84

1.6

1.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

507

3352

1.52

17.69

1.3

1.4

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.61

17.66

1.9

2.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

198

3.29

17.50

1.7

1.6

0.92

1.77

mg/l

1.32

141

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

313

1852

1.70

17.35

2.8

2.6

876.30

664.25

e6/l

4.86

302

1788

(3013293) Extractable nuclear Ab [Presence] in Serum

361

2.63

17.25

1.8

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

507

3376

1.51

17.12

6.3

11.68

11.60

mg/l

0.16

469

3089

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

298

1748

1.71

17.06

1.3

1.4

13.25

12.15

umol/l

1.65

280

1659

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

493

3271

1.51

16.94

1.3

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

429

2763

1.56

16.89

2.7

2.5

1.31

1.27

g/24h

0.11

219

1368

(3016650) Hepatitis A virus Ab [Presence] in Serum

585

4045

1.45

16.37

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

236

1314

1.80

16.23

1.6

1.15

1.23

nmol/l

0.60

197

1017

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

415

2678

1.56

16.22

1.4

1.7

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

939

12373

0.75

16.13

1.4

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

586

4067

1.45

16.09

1.2

1.1

12.13

11.93

au/ml

0.02

237

(3004809) Band form neutrophils/100 leukocytes in Blood

590

4106

1.44

15.97

3.4

3.3

1.46

1.50

0.11

552

3621

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1098

8443

1.31

15.96

2.6

2.7

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

350

2179

1.61

15.95

1.4

1.3

1.58

1.41

nmol/l

2.24

313

1967

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

459

3040

1.52

15.94

1.7

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

392

2521

1.56

15.58

1.9

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

588

4113

1.44

15.50

1.5

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

588

4115

1.44

15.46

1.5

1.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

314

1920

1.64

15.41

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

485

3281

1.48

15.22

1.3

1.4

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

101

4.06

15.09

1.4

1.6

0.13

0.32

u/l

0.53

(3008116) Ketones [Moles/volume] in Urine by Test strip

111

485

2.29

14.99

1.5

1.4

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

223

2.96

14.99

1.3

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

176

923

1.91

14.68

2.1

2.2

60.55

63.60

ug/l

0.26

170

902

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

681

4942

1.39

14.57

1.4

1.3

269.59

270.46

u/ml

0.03

438

3148

(3034770) Mitochondria Ab [Titer] in Serum

908

6892

1.33

14.51

1.2

678.00

992.04

titre

1.20

206

(3005988) Vibrio sp identified in Specimen by Organism specific culture

477

3250

1.47

14.47

1.3

1.4

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

315

1960

1.61

14.45

1.2

34.26

45.63

u/ml

0.50

152

(3025468) Yersinia sp identified in Specimen by Organism specific culture

476

3243

1.47

14.44

1.3

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

476

3247

1.47

14.36

1.3

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

611

4367

1.41

14.31

1.4

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

945

7228

1.32

14.31

1.1

7.19

6.16

u/ml

0.13

932

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

216

1218

1.78

14.31

2.5

2.3

201.20

203.81

u/l

0.23

216

1208

(3004716) Salmonella sp identified in Stool by Organism specific culture

1610

13151

1.24

14.24

1.3

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

715

5253

1.37

14.19

1.3

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

168

878

1.92

14.18

2.0

2.8

1.50

1.24

ug/l

0.61

158

835

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

6.15

14.16

1.2

1.4

17.87

84.11

e6/l

1.33

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

313

1956

1.61

14.12

1.2

70.75

71.18

u/ml

0.01

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

421

2812

1.50

14.10

2.8

3.3

4.60

8.62

nmol/l

1.21

410

2718

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

213

1202

1.78

14.08

3.0

1.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

913

6984

1.32

13.83

1.2

1.3

112.64

127.91

titre

0.37

627

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

301

1873

1.61

13.83

1.2

3.35

11.01

u/ml

1.99

128

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

718

5303

1.36

13.80

1.5

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

239

1403

1.71

13.76

1.5

1.3

3.95

5.02

umol/l

4.49

218

1283

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

705

5196

1.36

13.73

5.2

5.9

797.19

1220.40

iu/ml

0.53

793

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

198

2.98

13.60

1.3

1.4

8.27

15.90

pmol/l

1.60

169

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

387

2562

1.52

13.55

2.2

2.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

346

2.46

13.50

1.2

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

317

2010

1.58

13.47

1.2

48.63

53.54

u/ml

—

101

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

158

3.23

13.45

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

419

2828

1.49

13.37

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

272

1666

1.64

13.34

1.2

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

544

3860

1.42

13.32

1.4

1.5

0.35

0.40

nmol/l

0.65

405

3000

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

862

6586

1.32

13.19

1.9

1.7

41.70

42.72

nmol/l

0.55

844

6389

(3050129) First trimester maternal screen panel - Serum or Plasma

616

8377

0.73

13.15

1.4

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

197

2.95

13.11

1.7

1.6

2.28

2.65

mg/l

0.16

141

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

197

2.95

13.11

1.7

1.6

3.09

1.65

mg/l

0.86

126

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

197

2.95

13.11

1.7

1.6

1.14

0.96

mg/l

0.10

138

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

197

2.95

13.11

1.7

1.6

2.68

2.00

mg/l

0.32

150

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

197

2.95

13.11

1.7

1.6

1.66

1.16

mg/l

0.32

132

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

197

2.95

13.11

1.7

1.6

4.38

4.01

mg/l

0.14

130

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

197

2.95

13.11

1.7

1.6

1.90

2.08

mg/l

0.07

134

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

197

2.95

13.11

1.7

1.6

3.83

2.81

mg/l

0.41

138

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

197

2.95

13.11

1.7

1.6

1.68

1.54

mg/l

0.10

144

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

560

4021

1.40

12.83

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

531

3782

1.41

12.75

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4442

39832

1.13

12.66

1.7

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

865

6653

1.31

12.63

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

465

3247

1.44

12.48

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

160

860

1.86

12.46

1.2

0.32

0.51

g/l

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

145

755

1.92

12.45

2.7

3.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

878

6782

1.30

12.42

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

260

2.62

12.34

2.3

2.7

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

702

5270

1.34

12.18

1.5

14.37

20.65

u/ml

—

105

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

305

1969

1.55

12.05

1.8

1.9

3.58

3.85

mg/l

0.49

292

1861

(3034274) Bile acid [Moles/volume] in Serum --fasting

479

3387

1.42

12.02

2.0

2.3

7.12

7.60

umol/l

0.20

351

2493

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

595

4367

1.37

11.97

1.6

1.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

904

7052

1.29

11.89

5.0

4.4

1.52

mg/l

0.05

833

6488

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

306

2.42

11.44

1.1

—

(3049233) Organic acids panel - Urine

4.81

11.39

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

519

3758

1.39

11.37

1.3

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

516

3743

1.38

11.19

1.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

266

1696

1.57

11.14

1.1

9.88

7.91

iu/ml

0.56

407

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

240

2.58

11.02

1.2

1.1

1.62

1.72

umol/24h

0.34

240

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

181

1051

1.73

10.96

1.6

1.5

1485416.67

2157088.07

iu/ml

0.48

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

279

1806

1.55

10.94

1.5

1.6

27.13

24.78

u/ml

0.24

379

(3051593) INR in Capillary blood by Coagulation assay

193

1143

1.69

10.88

9.4

10.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

370

2543

1.46

10.87

3.6

3.3

56.01

57.10

0.46

338

2104

(3034891) Synovial lining cells/100 cells in Synovial fluid

198

1181

1.68

10.87

1.5

3.68

3.64

0.01

271

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

181

3014

0.60

10.81

1.2

—

(3012565) Volume of 24 hour Urine

207

1252

1.66

10.78

2.2

1909.55

1933.56

0.10

184

1098

(3052592) Norovirus Ag [Presence] in Stool

101

489

2.07

10.71

1.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.83

10.61

1.4

1.3

538.10

518.39

nmol/l

0.06

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

4642

42151

1.12

10.57

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

641

4854

1.33

10.54

1.5

106.00

113.53

u/ml

1.05

175

1049

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

439

3132

1.41

10.54

1.5

1.6

57.49

57.68

0.03

260

2001

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

4.46

10.45

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

225

1404

1.61

10.36

3.1

2.7

42.79

38.92

2.94

172

755

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

342

2344

1.46

10.23

2.6

2.8

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

305

2045

1.50

10.19

2.0

2.1

1.86

2.20

u/field

0.56

148

849

(40761539) Cells [Type] in Urine sediment by Light microscopy

119

623

1.91

10.15

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

775

6058

1.29

10.10

2.3

110.13

113.36

ug/min

0.07

478

3586

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

4.19

10.06

1.1

—

mmol/l

—

(3003338) MCHC [Mass/volume]

22550

219866

1.09

10.02

25.3

17.7

332.42

332.32

g/l

0.89

22406

218108

(3019832) Treponema pallidum Ab [Presence] in Serum

2826

24973

1.14

9.98

1.6

1.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

268

4007

0.67

9.93

1.5

1.6

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

397

2823

1.41

9.75

1.5

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

220

1391

1.58

9.63

1.2

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

396

2823

1.41

9.60

1.5

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

535

4006

1.34

9.55

2.7

3.2

471.71

5211.92

u/ml

1.27

248

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

385

2736

1.41

9.50

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1087

8901

1.23

9.49

2.0

1.8

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

189

2.65

9.38

1.4

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

314

2155

1.46

9.38

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

314

2155

1.46

9.38

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

314

2155

1.46

9.38

1.5

1.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

385

2744

1.41

9.36

1.2

70.10

63.26

u/l

0.30

342

2452

(3028679) Herpes simplex virus Ab [Presence] in Serum

210

1327

1.59

9.24

1.2

—

(3017509) Phencyclidine [Presence] in Urine

262

2.37

9.22

2.3

1.5

—

(3017704) Immunofixation for Urine

210

1331

1.58

9.13

1.5

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

738

5827

1.27

8.93

1.4

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

219

2.47

8.80

1.1

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

337

2373

1.42

8.80

1.5

30.36

30.58

0.03

176

1494

(40768443) Skin Pathology biopsy report

1349

11391

1.19

8.59

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

512

3873

1.33

8.58

1.2

1.3

22.39

37.27

u/l

5.82

454

3349

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

181

2.60

8.53

1.2

32.88

24.34

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1134

9430

1.21

8.52

1.6

—

(3051651) Icteric interference index of Serum or Plasma

239

1586

1.51

8.49

3.9

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

177

1100

1.61

8.40

4.7

4.5

78.81

1680.59

mg/l

2.55

125

795

(40757494) Bilirubin.total [Moles/volume] in Blood

208

1343

1.55

8.38

2.0

2.2

44.42

41.69

umol/l

0.08

145

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

263

1785

1.48

8.37

1.4

12.15

12.77

u/l

0.95

255

1719

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

346

2471

1.40

8.37

1.5

1.7

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

195

2.51

8.33

3.0

2.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

144

2.78

8.28

1.2

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

369

2670

1.39

8.27

1.1

98.18

94.77

1.61

338

2500

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

618

4824

1.29

8.23

1.6

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

4.07

8.23

2.0

2.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

378

2753

1.38

8.15

1.6

1.5

34.56

31.19

iu/ml

0.15

132

(3007463) Buprenorphine [Presence] in Urine

3.30

8.03

4.9

6.5

—

(3019174) dRVVT (LA screen)

217

2.40

8.01

1.1

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

831

6750

1.24

7.90

2.0

1.7

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

256

2.27

7.88

1.1

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

4.61

7.85

1.8

1.3

128.44

138.36

nmol/l

—

(3000093) Morphology [Interpretation] in Blood Narrative

341

2459

1.39

7.83

1.2

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

375

2752

1.37

7.74

3.6

3.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

116

660

1.76

7.70

1.6

9.66

9.00

ug/l

0.78

116

660

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

259

2.24

7.67

2.2

2.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

300

4179

0.71

7.65

3.3

3.5

25.43

37.88

u/ml

2.94

291

4037

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

318

2.11

7.63

1.1

1.0

0.24

0.36

u/ml

0.19

200

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

615

4848

1.27

7.61

1.8

1.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

528

4084

1.30

7.59

1.1

—

(3042951) Complement C1q Ab [Units/volume] in Serum

103

3.01

7.43

1.7

1.2

30.00

16.87

u/ml

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

297

2113

1.41

7.41

1.2

78.95

189.68

titre

7.50

372

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

204

1352

1.51

7.36

1.5

—

(3013466) aPTT in Blood by Coagulation assay

137

2.70

7.30

1.0

1.1

38.99

37.05

0.40

115

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

202

1340

1.51

7.26

1.5

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

295

2108

1.40

7.19

1.2

317.00

114.65

titre

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

453

3462

1.31

7.15

1.5

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

236

1622

1.46

7.13

1.3

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

197

1309

1.51

7.04

1.5

1.9

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

158

1000

1.58

7.03

2.5

2.8

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.48

6.96

1.1

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

134

818

1.64

6.92

2.7

2.8

221.53

146.43

au/ml

0.81

107

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

196

1308

1.50

6.88

1.5

1.9

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

187

1237

1.51

6.85

1.1

2.80

4.17

iu/ml

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

360

2682

1.35

6.80

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

502

1.81

6.76

1.3

1.2

0.64

43.13

mg/l

1.68

373

(3030313) Adrenal Ab [Titer] in Serum

235

2.21

6.74

1.2

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

127

772

1.65

6.69

1.2

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

125

757

1.65

6.68

1.1

—

(44813793) Dust mix specific IgE antibody measurement

264

1877

1.41

6.66

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

237

1653

1.44

6.66

1.3

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

541

1.78

6.65

1.3

1.2

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.00

6.60

1.2

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

105

2.86

6.60

1.2

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

745

6107

1.22

6.57

1.6

17381.51

13231.92

e6/l

0.92

580

4425

(1617658) Protocol used for examination of sentinel lymph nodes

121

1953

0.62

6.57

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

496

1.80

6.42

2.3

2.4

7.67

7.52

mmol/l

0.11

297

(3014051) Protein [Presence] in Urine by Test strip

809

6707

1.21

6.39

2.7

2.5

—

(3003694) ABO and Rh group [Type] in Blood

7678

72764

1.07

6.36

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

3157

28834

1.10

6.32

1.6

1.7

—

(3026250) Tacrolimus [Mass/volume] in Blood

173

1147

1.51

6.31

36.4

35.3

7.36

7.21

ug/l

0.36

163

1036

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

144

921

1.57

6.19

2.0

1.9

157.86

165.21

0.39

135

870

(3016244) Insulin [Units/volume] in Serum or Plasma

237

1677

1.42

6.18

3.0

3.2

22.79

27.01

mu/l

0.93

221

1580

(3028433) Virus identified in Specimen by Culture

136

862

1.58

6.09

1.1

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.75

6.07

1.0

1.1

2.00

2.63

0.71

(3017732) Neutrophils [#/volume] in Blood

2014

17988

1.13

6.06

2.9

2.8

5.68

4.93

e9/l

0.97

1655

14404

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

219

1536

1.43

6.02

1.5

1.4

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

138

883

1.56

5.94

3.0

3.4

8.23

7.83

mg/l

0.31

116

698

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

295

2.00

5.94

2.2

2.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

226

1599

1.42

5.92

1.6

7.84

6.90

u/l

0.47

176

1288

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

216

2.18

5.89

1.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

563

1.71

5.85

1.1

1.2

87.29

87.30

0.00

152

(1761482) Bacteria [#/volume] in Urine by Culture

541

6693

0.80

5.83

5.2

4.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

166

1111

1.50

5.82

2.5

2.3

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

361

1.88

5.77

4.7

59.67

42.85

ug/min

0.91

287

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

504

4025

1.26

5.72

1.4

1.3

27.09

27.35

u/l

0.06

429

3290

(3045177) Copper [Moles/volume] in Urine

5.16

5.68

1.1

0.22

0.57

umol/l

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

422

1.80

5.61

2.5

2.6

71.47

54.97

mg/l

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

338

2573

1.32

5.60

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

612

5005

1.23

5.60

2.4

1.9

0.93

0.82

nmol/l

3.06

515

4188

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

563

1.69

5.59

1.1

68.72

74.42

0.60

146

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

192

1334

1.44

5.59

1.1

24.37

23.95

u/l

0.02

175

1195

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

231

1659

1.39

5.58

1.4

1.7

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

101

609

1.66

5.57

1.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

282

2096

1.35

5.51

1.1

—

(3003577) Lead [Moles/volume] in Blood

171

2.28

5.49

1.1

1.4

0.14

0.19

umol/l

0.30

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

462

1.75

5.47

1.1

1.2

—

(3034988) Calcium [Moles/volume] in Capillary blood

478

1.74

5.43

1.7

3.1

1.19

mmol/l

0.27

459

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

190

1334

1.43

5.26

1.1

82.35

83.97

u/l

0.08

174

1197

(3012864) Amino acids [Identifier] in 24 hour Urine

+∞

5.21

1.2

0.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

655

5442

1.21

5.15

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

217

1567

1.39

5.12

1.3

1.2

109.07

88.79

u/l

0.91

180

1370

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.79

5.12

1.2

256.31

281.07

nmol/l

0.22

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

421

1.76

5.07

1.2

1.5

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

218

1580

1.38

5.04

1.2

1.3

99.00

432.42

titre

—

128

(3005011) Chlamydia sp Ab [Titer] in Serum

364

1.81

5.02

1.6

—

(3021788) Differential panel - Synovial fluid

566

4652

1.22

4.98

1.6

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1148

0.57

4.95

1.2

1.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

212

1537

1.38

4.91

1.2

1.3

55.00

59.22

titre

0.10

128

(3036312) Salmon IgE Ab [Units/volume] in Serum

142

2.32

4.89

1.0

1.1

0.50

1.61

u/ml

0.80

105

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

396

3146

1.26

4.78

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

407

1.75

4.77

1.5

1.8

100.79

48.50

pmol/l

0.41

338

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

113

2.48

4.77

1.1

1.0

0.09

0.16

u/ml

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.88

4.74

1.2

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

125

829

1.51

4.68

2.1

9.65

9.21

mg/l

0.37

105

670

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

421

3378

1.25

4.67

1.1

1.51

g/l

0.08

395

3046

(3035060) Mercury [Moles/volume] in Blood

5.00

4.62

1.5

1.9

5.43

17.51

nmol/l

1.72

(3018001) Oat IgE Ab [Units/volume] in Serum

166

2.17

4.56

1.1

1.0

0.15

0.32

u/ml

0.66

101

(3013727) Leukocytes other/100 leukocytes in Blood

124

826

1.50

4.56

3.4

3.5

55.84

52.53

1.07

119

800

(3045683) HLA typing for celiac disease panel - Blood or Tissue

207

1517

1.37

4.52

1.0

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

326

1.81

4.51

2.6

2.4

1.92

1.34

mmol/l

0.65

230

(3018133) Calcium [Moles/volume] in Urine

467

1.67

4.50

2.3

2.73

2.64

mmol/l

0.15

419

(4094501) Cardiovascular stress test using bicycle ergometer

778

6648

1.17

4.50

1.1

—

(40768793) Breast Pathology biopsy report

477

5806

0.82

4.50

1.3

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

422

3403

1.24

4.50

3.1

2.6

13.18

13.17

0.03

417

3359

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

115

757

1.52

4.48

1.1

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

115

757

1.52

4.48

1.2

1.3

37.64

40.12

g/l

1.10

392

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1210

10689

1.14

4.43

4.6

4.4

24.81

24.75

mmol/l

0.31

1125

9915

(3010015) Selenium [Moles/volume] in Serum or Plasma

230

1.96

4.36

1.8

2.2

1.22

1.31

umol/l

0.92

211

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

106

690

1.54

4.35

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

100

643

1.56

4.34

1.4

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

4.24

4.30

1.0

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

385

3091

1.25

4.29

1.8

1.9

21.01

24.15

ug/l

0.39

377

3023

(4281824) Cell count and differential, peritoneal fluid

213

2838

0.75

4.29

1.2

1.1

—

(3047189) Immunofixation for 24 hour Urine

156

1101

1.42

4.28

1.7

1.8

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

3.84

4.18

1.0

10413.67

11964.30

ng/l

—

(3014271) Vancomycin [Susceptibility]

179

1300

1.38

4.17

3.4

2.9

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

206

1530

1.35

4.17

1.2

30.00

23.52

u/l

0.64

164

1313

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

226

1703

1.33

4.15

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2092

19142

1.10

4.10

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

305

2400

1.27

4.06

3.3

4.8

97.20

114.76

u/ml

0.20

740

(3017315) Amylase [Enzymatic activity/volume] in Urine

193

1426

1.35

4.05

1.1

1.3

254.86

325.61

u/l

0.71

177

1321

(3002621) Streptococcal DNAse B [Units/volume] in Serum

265

1.85

4.04

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

485

4017

1.21

4.04

1.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

338

1.75

4.04

1.2

1.3

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

230

1.91

4.03

1.0

1.1

0.03

0.47

u/ml

2.02

127

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

616

1.54

4.01

1.3

40.13

36.87

0.37

405

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

199

1481

1.35

3.99

1.5

1.4

—

(40762365) Oxygen content in Arterial blood by calculation

415

1.66

3.97

2.5

3.0

15.09

14.76

ml/dl

0.44

388

(3012494) Peanut IgE Ab [Units/volume] in Serum

118

803

1.47

3.96

1.1

0.50

8.35

u/ml

1.27

469

(3002256) Pathology report gross observation

3627

34023

1.07

3.90

1.3

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.25

3.89

1.9

1.2

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

7.27

3.85

1.0

1.1

25.00

18.09

umol/l

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

113

2.30

3.83

40.2

5.7

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.68

3.81

3.7

3.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

302

2397

1.26

3.78

1.3

1.4

109610.34

124284.79

e6/l

0.17

210

1666

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

988

8721

1.14

3.73

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

136

963

1.41

3.72

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

362

1.69

3.71

1.4

6.74

189708.54

nmol/l

1.67

301

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

252

1.83

3.68

1.0

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

455

1.60

3.68

2.0

1.5

0.15

0.23

nmol/l

1.80

326

(40757373) Influenza virus identified in Isolate

497

1.57

3.59

1.5

1.6

—

(3035880) pH of Pleural fluid

178

1327

1.34

3.58

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

515

4344

1.19

3.57

1.1

1.78

1.94

u/ml

0.15

283

2240

(3036782) Glucose [Moles/volume] in Pleural fluid

286

2274

1.26

3.55

1.3

6.38

6.29

mmol/l

0.24

267

2098

(3000285) Sodium [Moles/volume] in Blood

300

1.73

3.52

1.2

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

3.04

3.52

1.0

0.15

1.21

u/ml

—

(3008037) Lactate [Moles/volume] in Venous blood

636

5469

1.17

3.50

3.6

3.2

1.52

1.59

mmol/l

0.78

618

5357

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

165

1221

1.35

3.49

2.4

2.1

125.08

104.84

ug/min

0.17

268

(3006576) Bicarbonate [Moles/volume] in Blood

126

893

1.41

3.46

5.5

6.6

25.18

24.94

mmol/l

0.28

115

819

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

370

1.65

3.45

1.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

101

2.28

3.34

1.1

1.0

0.02

0.10

u/ml

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

160

1188

1.35

3.33

3.3

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

175

1.94

3.31

1.4

2.0

181.70

179.43

ug/g

0.02

152

(3002619) Bacteria identified in Specimen by Culture

532

1.52

3.30

1.3

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

100

686

1.46

3.30

1.9

2.0

19.96

39.55

u/l

2.11

623

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

307

1.69

3.27

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.38

3.21

1.1

1.0

—

(3034426) Prothrombin time (PT)

119

848

1.40

3.20

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

553

4741

1.17

3.20

3.3

3.1

0.81

nmol/l

0.11

431

3648

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

6.36

3.18

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

346

2848

1.22

3.17

4.0

3.6

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.95

3.12

1.2

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

300

2440

1.23

3.10

3.5

3.8

—

(3023199) Leukocytes [#/volume] in Pleural fluid

358

2968

1.21

3.06

1.4

1.5

4737.31

2892.41

e6/l

0.34

277

2131

(3014133) Dog dander IgE Ab [Units/volume] in Serum

434

3666

1.19

3.03

1.1

4.12

4.35

u/ml

0.12

233

1770

(3006922) Hepatitis E virus Ab [Presence] in Serum

225

1777

1.27

3.02

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

437

0.48

2.98

2.0

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

436

0.48

2.96

4.0

6.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

242

1935

1.25

2.94

3.3

2.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

134

2.01

2.94

1.1

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

130

1748

0.74

2.93

1.4

1.5

—

(40768446) Kidney Pathology biopsy report

137

1017

1.35

2.91

1.7

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

257

1.71

2.91

2.1

2.6

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

191

1.83

2.90

1.3

2.8

2.57

55.20

pmol/l

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

673

1.43

2.87

1.9

1.7

143.84

143.43

au/ml

0.00

(3007542) Rye IgE Ab [Units/volume] in Serum

115

2.09

2.87

1.1

1.0

0.16

0.46

u/ml

0.58

(3041918) Cholesterol [Moles/volume] in Pleural fluid

453

1.52

2.86

1.2

1.66

1.64

mmol/l

0.04

274

(3006270) Folate [Moles/volume] in Blood

265

2151

1.23

2.83

1.2

371.21

356.15

nmol/l

0.60

219

1794

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

132

980

1.35

2.82

3.1

2.4

—

(3036603) Volume of Urine

215

1706

1.26

2.81

1.6

1.5

2269.12

1912.84

2.23

210

1656

(3016031) Almond IgE Ab [Units/volume] in Serum

179

1.84

2.80

1.1

1.0

0.17

1.03

u/ml

3.57

108

(4034850) Laboratory test

923

8277

1.12

2.79

18.4

9.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

261

1.69

2.77

1.0

0.34

1.99

u/ml

0.60

140

(3010375) cycloSPORINE [Mass/volume] in Blood

154

1175

1.31

2.74

23.3

29.2

118.92

118.75

ug/l

0.01

118

999

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

207

1641

1.26

2.74

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

208

1650

1.26

2.73

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

585

5107

1.15

2.72

2.5

3.3

1398.22

791.02

u/ml

0.24

510

4662

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

459

1.50

2.71

1.0

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

412

3505

1.18

2.69

2.5

2.7

853.59

652.18

u/ml

0.17

403

3463

(4146454) Self-monitoring of blood glucose

227

2802

0.81

2.64

2.8

2.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

602

1.43

2.63

1.2

—

(3007700) Barley IgE Ab [Units/volume] in Serum

106

2.08

2.61

1.1

1.0

0.21

0.62

u/ml

0.66

(1002224) Polysomnography panel

1106

10060

1.10

2.58

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

531

6077

0.87

2.57

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

389

3308

1.18

2.57

1.5

32.54

32.92

g/l

0.23

344

2985

(3036005) Urine sediment comments by Light microscopy Narrative

3.60

2.57

1.0

1.2

—

(3032641) Amino acids panel - Urine

3.05

2.56

1.3

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

595

5226

1.14

2.55

1.2

1.1

1.77

2.03

u/ml

0.31

350

2659

(3025481) Topiramate [Mass/volume] in Serum or Plasma

5.45

2.54

1.7

2.8

2.97

8.42

mg/l

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

254

1.65

2.49

1.0

1.1

0.02

0.79

u/ml

1.32

138

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

619

1.41

2.46

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

116

1.98

2.44

3.3

4.6

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

303

1.58

2.42

1.2

1.3

55.38

300.54

u/l

0.91

213

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

105

774

1.36

2.40

1.1

1.0

7.41

10.89

u/ml

1.09

425

(43055442) Apixaban [Mass/volume] in Serum or Plasma

344

1.54

2.38

1.5

120.52

108.27

ug/l

0.29

289

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

449

1.47

2.37

4.2

6.1

—

(3012441) Differential panel - Pleural fluid

304

2552

1.19

2.37

1.4

1.5

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.21

2.36

3.0

6.9

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

599

1.40

2.36

1.4

1.6

0.44

0.39

ug/l

0.46

390

(3007456) Orange IgE Ab [Units/volume] in Serum

2.50

2.35

1.1

1.0

0.04

0.26

u/ml

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

898

8134

1.11

2.31

1.3

228.88

225.81

miu/ml

0.09

398

3736

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

229

1.66

2.31

1.3

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

112

1.96

2.29

3.4

4.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

395

4570

0.86

2.28

1.4

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

316

1.55

2.27

3.1

2.5

0.57

0.62

u/field

0.14

316

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4585

44018

1.05

2.27

3.0

0.71

0.78

ug/l

5.87

3011

29578

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

215

1.67

2.27

1.2

1.1

14.00

18.50

iu/ml

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

270

2253

1.20

2.27

1.3

533.99

492.64

u/l

0.09

257

2136

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

117

1530

0.76

2.26

1.2

1.3

1.55

g/l

0.01

117

1530

(3025549) Creatine [Moles/time] in 24 hour Urine

201

1.69

2.23

1.5

1.4

—

14.73

—

(3014891) Appearance of Pleural fluid

318

1.54

2.22

1.4

1.3

—

(3042628) Porphyrins [Moles/volume] in Urine

5.55

2.21

1.2

1.0

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

280

1.57

2.17

1.2

1.4

77.33

71.39

0.68

230

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

218

1.65

2.17

1.3

14.49

15.81

nmol/l

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

211

1.66

2.15

7.1

6.9

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

105

790

1.33

2.14

1.5

1.6

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

2.62

2.13

1.1

1.0

0.28

1.57

u/ml

—

(3009015) Lactate [Moles/volume] in Synovial fluid

266

1.58

2.12

1.1

1.3

5.17

6.39

mmol/l

1.25

125

(3020618) Glucose [Moles/volume] in Synovial fluid

2.10

2.11

1.1

1.0

5.37

5.22

mmol/l

0.09

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1240

0.75

2.09

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

546

1.39

2.08

1.1

0.66

2.99

u/ml

1.15

462

(3013931) Oligosaccharides [Presence] in Urine

5.00

2.07

1.2

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

5.00

2.07

1.4

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

185

1503

1.23

2.07

1.1

1.2

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

3.50

2.05

1.7

1.0

—

(3045424) Erythrocytes [Presence] in Urine

494

4365

1.13

2.02

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

317

2714

1.17

2.02

1.5

88594.99

50281.24

e6/l

0.95

207

1594

(3012989) Citrate [Moles/time] in 24 hour Urine

2.50

2.00

1.5

1.4

2.36

1.97

mmol/24h

0.54

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

373

3240

1.15

1.97

2.2

2.0

26.18

26.39

mg/l

0.02

875

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

2.28

1.97

8.4

8.6

33.83

45.86

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

316

2712

1.17

1.96

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

478

1.40

1.94

1.1

1.2

—

(40768795) Lymph node Pathology biopsy report

212

2541

0.83

1.93

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

362

1.46

1.93

1.8

2.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.73

1.92

1.1

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

916

8393

1.09

1.92

1.4

1.5

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

479

1.40

1.92

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

479

1.40

1.92

1.1

1.2

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

195

1.64

1.91

1.0

1.2

39.93

44.55

mg/l

—

(3020650) Glucose [Presence] in Urine

633

1.34

1.90

1.5

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

365

1.45

1.86

1.5

1.4

—

(3025130) Human papilloma virus identified in Specimen

315

3634

0.86

1.82

1.7

—

(3044941) Cell count panel - Synovial fluid

446

3946

1.13

1.82

1.5

1.4

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

137

1.75

1.82

1.0

1.1

48.67

105.34

u/l

0.62

109

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

154

1247

1.24

1.82

1.4

1.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

331

2871

1.15

1.81

2.4

2.5

—

(3051101) Glucose [Moles/volume] in Cord blood

453

0.62

1.81

3.8

5.8

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

154

1248

1.23

1.81

1.4

1.7

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

115

901

1.28

1.80

1.8

1.7

92751.69

22684.64

u/ml

0.44

120

(40759632) Porphyrins [Mass/mass] in Stool

3.04

1.79

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

390

3432

1.14

1.75

1.6

1.5

—

(3026480) Teichoate Ab [Titer] in Serum

217

1.57

1.72

1.1

—

2.22

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

156

1899

0.82

1.72

1.3

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

290

1.48

1.70

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

340

1.44

1.68

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

173

1433

1.21

1.67

1.4

1.3

5.82

5.70

mmol/l

0.83

151

1363

(3021162) Amylase [Enzymatic activity/volume] in Specimen

391

1.41

1.66

2.1

2.8

2527.52

1771.79

u/l

0.18

350

(3006567) Chloride [Moles/time] in 24 hour Urine

2.50

1.66

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

631

1.32

1.65

16.8

7.4

—

(3009871) Measles virus Ab [Titer] in Serum

110

869

1.27

1.64

1.7

—

(3020491) Glucose [Moles/volume] in Blood

227

1930

1.18

1.64

2.0

1.8

7.17

6.75

mmol/l

1.22

167

1395

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

368

1.41

1.62

1.2

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

427

1.38

1.62

1.2

1.1

3.88

7.82

pmol/l

—

(3007147) Virus identified in Stool by Electron microscopy

3.57

1.61

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

205

1.56

1.61

2.2

2.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

337

2961

1.14

1.58

1.1

0.21

0.40

u/ml

1.17

114

827

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

387

1.40

1.58

1.1

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.69

1.58

2.3

2.4

—

(3011325) HIV 1+2 Ab [Presence] in Serum

121

1.74

1.57

1.1

—

(3024316) Viscosity of Plasma

122

1.72

1.53

2.4

1.7

1.53

1.66

mpas

0.54

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

214

1824

1.17

1.53

1.6

—

(3045788) Cell count panel - Pleural fluid

264

2288

1.15

1.52

1.4

1.5

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

3.33

1.52

1.0

20.40

13.07

umol/l

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

130

1.69

1.52

1.0

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

536

1.32

1.51

1.2

1.3

153.42

68.48

mu/l

0.38

397

(3002814) Trichinella spiralis Ab [Titer] in Serum

2.59

1.51

1.1

1.0

—

(3015183) Erythrocyte sedimentation rate

152

1258

1.21

1.51

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

209

1783

1.17

1.48

1.3

14.07

13.72

u/l

0.06

187

1646

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.81

1.46

1.0

1.1

1.33

1.26

u/field

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.92

1.43

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

204

1.52

1.42

1.2

1.1

—

(40768800) Prostate Pathology biopsy report

431

4781

0.90

1.41

1.2

—

(3042733) HLA Ab [Presence] in Serum

108

870

1.24

1.41

4.6

4.9

—

(3023383) Lactate [Moles/volume] in Pleural fluid

754

1.26

1.41

1.2

1.3

3.68

3.47

mmol/l

0.27

699

(3041806) Other cells [#/volume] in Blood by Manual count

908

0.77

1.40

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

694

1.27

1.38

1.7

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

415

1.35

1.37

2.2

1.3

129.65

323.24

ng/l

0.45

264

(3023430) Cat dander IgE Ab [Units/volume] in Serum

384

3438

1.12

1.37

1.1

6.55

5.06

u/ml

0.39

171

1472

(3013945) Hepatitis B virus e Ab [Presence] in Serum

135

1.63

1.35

1.2

1.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

795

1.25

1.34

1.1

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

256

2239

1.14

1.34

1.2

1.3

—

titre

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

618

1.28

1.33

1.2

283.35

310.27

pmol/l

0.31

444

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.14

1.33

1.0

1.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.13

1.33

1.7

2.2

2.13

2.59

mu/l

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

516

4707

1.10

1.30

1.1

4.44

5.15

u/ml

0.59

271

2469

(3005082) Progesterone [Moles/volume] in Serum or Plasma

108

1318

0.82

1.30

1.1

1.4

25.67

31.21

nmol/l

1.25

1202

(3038071) Oxygen [Partial pressure] in Mixed venous blood

559

1.29

1.30

18.2

7.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.35

1.29

1.8

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

508

1.30

1.27

2.0

2.2

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

170

1.53

1.25

1.0

1.1

9.13

7.87

u/ml

0.13

122

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

154

1.56

1.25

4.4

4.8

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

619

1.26

1.20

1.5

1.4

11.93

13.77

g/l

1.21

469

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

147

1245

1.18

1.20

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

147

1245

1.18

1.20

1.3

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

306

3420

0.89

1.20

1.4

3.87

3.95

ug/l

0.04

264

3025

(3046861) Legionella sp Ag [Presence] in Urine

132

1.59

1.19

1.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

348

1.35

1.19

2.0

1.6

—

(3024263) Appearance of Synovial fluid

157

1338

1.17

1.19

1.2

1.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

306

1.37

1.18

1.2

1.3

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

167

0.54

1.18

1.0

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

350

1.34

1.16

1.2

1.3

1.34

1.46

mmol/l

0.05

218

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

102

1.67

1.15

1.1

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

124

1039

1.19

1.15

1.1

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

385

1.32

1.15

2.3

3.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1249

13159

0.95

1.15

1.7

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

174

1.49

1.14

1.2

1.1

—

2.25

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

150

1.53

1.13

1.2

1.8

0.77

0.68

umol/l

0.51

116

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

778

1.22

1.12

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

258

1.39

1.12

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

2.33

1.12

1.1

1.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

505

0.73

1.11

1.5

1.9

1.70

2.78

ug/l

1.03

305

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

379

1.32

1.11

1.2

1.3

43.33

41.20

mg/l

0.12

320

(36303858) Crystals [Presence] in Urine

1.95

1.08

1.0

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

405

3694

1.10

1.08

1.1

1.76

3.30

u/ml

4.06

159

1719

(3046682) IgA [Presence] in Skin by Immunofluorescence

2.19

1.08

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

592

5489

1.08

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

114

957

1.19

1.06

1.2

1.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

169

1.48

1.06

1.3

1.8

0.52

0.70

0.30

134

(3034614) HLA Ag [Interpretation]

1.92

1.05

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

551

1.25

1.04

1.9

1.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

178

1.46

1.04

1.2

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.96

1.03

2.0

2.1

—

(40762887) Creatinine [Moles/volume] in Blood

1.89

1.01

1.0

1.3

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

163

1.47

1.01

1.2

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

264

1.36

1.00

1.0

0.02

0.13

u/ml

3.17

161

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

191

1679

1.14

1.00

1.3

—

(3022475) Manganese [Moles/volume] in Blood

155

1.48

1.00

1.1

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

439

1.28

0.99

1.3

1.2

—

(3024932) HLA-DR beta [Type]

101

846

1.19

0.98

1.1

—

(3024471) HLA-A [Type]

103

866

1.19

0.97

1.0

—

(3018291) Platelet Ab [Presence] in Serum

1.94

0.97

1.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.96

0.0

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.89

0.94

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.77

0.94

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

430

3965

1.09

0.93

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

711

0.80

0.92

3.1

2.9

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

226

1.37

0.91

1.3

1.2

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.14

0.91

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

562

1.23

0.91

2.0

2.5

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

159

1.45

0.90

1.2

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

500

1.24

0.89

1.1

1.2

3.40

7.25

u/ml

0.59

366

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.07

0.89

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

283

3112

0.91

0.89

2.9

2.4

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

168

1.43

0.89

1.0

0.08

1.37

u/ml

1.01

125

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

385

3545

1.09

0.88

1.3

7.21

7.19

mmol/l

0.02

345

3113

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

120

1389

0.86

0.88

1.4

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

429

3970

1.08

0.87

1.1

—

(3022229) Phosphate [Moles/volume] in Urine

186

1.40

0.86

2.8

2.4

21.53

20.40

mmol/l

0.12

161

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

570

0.79

0.85

1.3

1.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

221

1.36

0.84

1.2

111.89

107.03

ug/l

0.06

139

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

778

1.18

0.84

2.3

1.8

2277.18

11469.18

e6/l

2.62

416

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

116

1001

1.16

0.83

1.2

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

844

8014

1.05

0.80

1.3

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

147

1.43

0.79

1.1

1.2

1.67

1.06

u/field

0.92

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.82

0.79

1.0

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

139

1.44

0.78

1.2

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

242

1.32

0.78

2.0

1.7

44.94

46.36

umol/l

0.07

242

(3020874) Milk IgE Ab [Units/volume] in Serum

185

1657

1.12

0.77

1.1

1.10

2.15

u/ml

0.76

596

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

251

1.31

0.77

3.7

3.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

612

1.19

0.76

2.5

2.8

130.30

112.80

ng/l

0.34

327

(3026470) Cobalt [Mass/volume] in Blood

173

1547

1.12

0.75

1.9

2.0

3.95

3.61

ug/l

0.16

159

1418

(3027974) Hepatitis B virus e Ag [Presence] in Serum

141

1.42

0.74

1.3

1.6

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

108

1.48

0.73

1.3

1.4

1.13

1.19

u/field

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

102

886

1.15

0.70

2.5

1.9

934.68

3389.25

e6/l

1.18

607

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

590

1.19

0.70

1.4

26.48

22.12

0.63

489

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

142

0.63

0.69

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

157

0.64

0.68

1.0

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

346

1.24

0.68

3.1

2.6

44.91

73.67

pmol/l

2.23

299

(3008401) Mugwort IgE Ab [Units/volume] in Serum

480

4517

1.06

0.67

1.1

0.67

1.10

u/ml

2.12

213

1979

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

886

9242

0.96

0.65

1.5

1.7

3.98

3.87

mg/l

0.13

681

6712

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.61

0.65

1.0

1.2

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

259

1.27

0.64

3.7

2.9

26.04

22.01

mg/l

1.03

241

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2584

26446

0.97

0.63

2.9

4.0

9.12

24.22

ug/l

8.61

2029

21362

(3010937) Rubella virus Ab [Presence] in Serum

146

1.37

0.63

1.0

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

341

1.23

0.63

1.4

1.2

20.12

20.57

mmol/l

0.31

297

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

164

1.34

0.62

2.0

1.7

—

(3001729) Color of Synovial fluid

199

1.31

0.61

1.3

1.7

—

(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay

1.67

0.61

1.0

1.2

78.60

85.36

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

125

1119

1.12

0.58

1.2

1.1

—

(40762814) Titanium [Mass/volume] in Blood

453

0.82

0.57

2.4

2.3

3.39

3.72

ug/l

0.28

164

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

114

0.61

0.57

8.0

9.0

—

(3004775) Volume in Urine collected for unspecified duration

188

2049

0.92

0.57

2.3

668.84

675.19

0.08

134

1398

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

1.48

0.56

2.1

2.3

0.08

0.35

ug/l

1.07

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

222

1.26

0.53

1.1

—

(40768806) Pleura Pathology biopsy report

275

2568

1.07

0.53

1.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

241

1.24

0.52

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

152

1.32

0.51

1.4

1.3

—

(46235168) Fasting glucose [Moles/volume] in Blood

292

0.79

0.51

1.4

2.1

9.46

7.46

mmol/l

—

119

(3032868) Hemoglobin electrophoresis panel in Blood

215

1.26

0.50

1.4

1.6

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

324

1.20

0.50

12.6

9.9

0.34

0.42

umol/l

0.42

292

(3007919) Fasciola sp Ab [Titer] in Serum

1.55

0.48

1.1

1.0

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

307

1.20

0.48

1.1

3.72

2.93

u/ml

0.12

241

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

207

1923

1.08

0.48

1.4

1.6

8.24

7.78

mmol/l

2.50

198

1846

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

164

1.28

0.46

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

162

1752

0.92

0.45

1.5

1.3

169.93

172.09

pmol/l

0.07

162

1752

(3011841) English Walnut IgE Ab [Units/volume] in Serum

301

1.20

0.45

1.0

1.1

5.20

6.22

u/ml

0.10

237

(3002331) Protein [Mass/volume] in Peritoneal fluid

543

1.14

0.44

1.5

1.4

23.99

39.75

g/l

0.80

423

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

654

6292

1.04

0.44

1.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

883

9115

0.97

0.44

2.6

3.4

904.44

1475.83

u/ml

0.45

734

7802

(3013166) Neutrophils/100 leukocytes in Synovial fluid

789

1.12

0.44

1.3

1.4

61.69

54.59

1.00

678

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.45

0.44

2.5

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

121

1.32

0.44

1.1

1.2

—

(3016750) Collection duration of Urine

161

1488

1.08

0.44

2.4

2.2

503.54

500.18

min

0.17

119

1111

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

211

1.23

0.43

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

128

1394

0.92

0.43

2.0

1.7

—

(44786800) Granulocytes/100 leukocytes in Body fluid

317

0.82

0.42

1.2

1.3

21.53

23.85

0.13

246

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.63

0.42

1.2

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.43

0.41

10.5

8.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

444

4247

1.05

0.41

1.2

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(3000330) Specific gravity of Urine by Test strip

1257

12884

0.97

0.41

3.8

3.5

—

(3048879) Bone marrow aspiration report

728

1.11

0.40

1.6

1.8

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

213

1.22

0.40

3.6

2.0

49.64

60.89

0.55

134

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

114

1043

1.09

0.40

1.2

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.47

0.40

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.47

0.40

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.47

0.40

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.47

0.40

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.47

0.40

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.47

0.40

2.0

—

(3045142) Bone marrow Pathology biopsy report

291

2756

1.06

0.40

1.3

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.43

0.39

1.2

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

327

3110

1.05

0.39

1.3

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.39

0.0

1.2

—

29.04

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

151

1.26

0.38

1.2

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

363

1.16

0.38

1.3

1.1

—

(3001556) Androgen free Index in Serum or Plasma

244

1.19

0.36

1.5

1.2

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

189

1.22

0.35

1.0

0.28

1.78

u/ml

1.56

132

(40765089) Chromosome analysis panel - Blood by G-banded

733

0.90

0.35

1.0

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

679

1.10

0.34

1.4

20.98

21.41

0.04

612

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

111

1025

1.08

0.34

1.9

—

(3033799) Differential panel - Peritoneal fluid

766

1.10

0.34

2.4

1.8

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

124

1151

1.08

0.33

1.7

2.2

19.51

260.03

ug/l

1.80

118

1090

(21494434) Karyotype in Bone marrow

229

2170

1.06

0.33

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

109

1.28

0.33

1.4

1.3

—

(4035726) Immunohistochemistry procedure

2292

22553

1.02

0.33

1.4

—

(3013762) Body weight Measured

0.67

0.32

1.5

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

692

1.10

0.32

1.2

1.3

226.68

309.80

ug/l

0.24

375

(3041354) Potassium [Moles/volume] in Venous blood

302

3154

0.96

0.32

2.7

2.4

4.03

4.06

mmol/l

0.71

302

3127

(3035933) Granulocytes/100 leukocytes in Blood

741

1.09

0.31

2.1

1.6

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

110

1.27

0.31

1.3

3.7

—

0.00

estimate

—

(3000034) Microalbumin [Mass/volume] in Urine

247

2352

1.05

0.31

2.9

3.0

64.05

48.45

mg/l

0.27

173

1678

(42870560) Thyrotropin [Units/volume] in Cord blood

276

1.16

0.31

1.0

8.63

9.20

mu/l

0.20

224

(3035285) Chloride [Moles/volume] in Venous blood

302

3151

0.96

0.31

2.7

2.4

105.52

105.65

mmol/l

0.19

302

3123

(3006462) Nitrate [Presence] in Urine

137

1282

1.07

0.31

3.1

3.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.71

0.30

1.0

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

536

5198

1.03

0.29

3.9

3.3

7.26

7.58

mmol/l

1.85

521

5104

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

185

1.19

0.29

4.5

—

(40765096) Chromosome analysis panel by Banding

711

0.91

0.28

1.2

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

298

1.14

0.28

1.6

1.4

—

(40758358) Immune stain study

119

0.76

0.27

1.0

—

(3044007) Cell count panel - Peritoneal fluid

700

1.09

0.27

2.5

1.8

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

203

1934

1.05

0.27

1.6

1.8

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.23

0.27

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

207

1.16

0.24

3.9

3.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

226

1.15

0.24

1.4

1.3

1.34

1.57

ml/s/173m2

0.25

151

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2546

25165

1.01

0.23

1.4

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.76

0.22

1.0

162.71

164.45

g/l

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

607

5932

1.02

0.21

1.4

101.09

141.65

pmol/l

2.80

583

5792

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

1.19

0.21

2.4

2.3

67.78

10.24

ng/l

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

6.3

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.22

0.21

1.0

1.2

3245.17

2437.39

ng/l

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

154

1.17

0.21

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

916

1.06

0.20

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

317

1.10

0.19

1.1

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

109

1.19

0.18

1.2

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

153

0.85

0.18

1.5

1.4

287.00

331.39

umol/24h

0.57

153

(3015076) Soybean IgE Ab [Units/volume] in Serum

150

1441

1.04

0.17

1.0

0.28

1.16

u/ml

1.40

405

(3001893) Eosinophils/100 leukocytes in Pleural fluid

756

1.06

0.17

1.3

1.4

2.01

2.88

0.57

634

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

167

1.14

0.16

3.6

2.0

15.67

18.05

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.14

0.16

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

1.20

0.16

1.2

—

(3022670) pH of Venous cord blood

0.75

0.15

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

314

1.08

0.14

10.7

7.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

393

1.07

0.13

1.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

543

5506

0.99

0.12

1.6

1.8

—

(3022689) Creatine [Moles/volume] in Urine

742

0.96

0.12

1.4

1.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

885

1.04

0.11

1.4

70.28

62.65

1.39

724

(3025577) Chromium [Mass/volume] in Blood

156

1517

1.03

0.11

2.1

2.56

2.28

ug/l

0.23

136

1256

(1761868) Lipid panel - Serum or Plasma

8972

89426

1.00

0.11

2.9

2.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

887

1.04

0.11

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

244

2389

1.02

0.11

1.2

1.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

117

1206

0.97

0.10

5.7

2162.00

3625.09

u/ml

0.17

224

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

144

1.11

0.10

5.1

3.3

—

(40768441) Liver Pathology biopsy report

194

1896

1.02

0.10

1.5

1.3

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

371

0.94

0.09

1.3

1.4

10.17

10.75

0.07

187

(3029612) Listeria sp Ab [Titer] in Serum

1.09

0.09

1.2

1.3

—

(4212803) Bone marrow aspirate examination

223

1.08

0.09

1.0

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.11

0.09

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

166

1624

1.02

0.08

1.1

0.57

6.58

u/ml

2.03

456

(40763480) Human metapneumovirus Ag [Presence] in Specimen

136

1.10

0.08

1.3

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

163

1595

1.02

0.08

5.3

6.6

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

122

1250

0.98

0.08

1.1

4.77

8.93

u/ml

1.89

212

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.03

0.07

1.0

1.1

—

(3008607) Semen analysis panel

112

0.89

0.07

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

147

1.09

0.07

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.05

0.07

1.1

1.0

—

(3013862) HLA-DP [Type]

0.88

0.06

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1361

13667

1.00

0.06

2.6

3.4

37.92

56.57

u/ml

3.15

1305

13199

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

405

1.04

0.05

1.4

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

103

1048

0.98

0.04

1.7

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

103

1048

0.98

0.04

1.7

2.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

200

0.95

0.04

1.1

1.0

—

(40758292) HTLV I+II Ab panel - Serum

390

1.03

0.02

1.2

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

379

0.98

0.02

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

198

0.96

0.02

1.2

1.1

—

(3006598) pH of Arterial cord blood

232

1.03

0.02

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

232

1.03

0.02

1.0

-1.79

-2.60

mmol/l

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

267

1.01

0.00

1.2

1.1

18.18

20.36

u/l

0.33

176

(3018738) Hemoglobin F/Hemoglobin.total in Blood

195

0.97

0.00

5.1

3.2

14.62

11.79

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

417

1.01

0.00

5.5

7.5

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.02

0.00

1.0

1.1

104.40

225.50

pmol/l

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.02

0.00

1.1

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

297

1.01

0.00

1.1

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

207

1.01

0.00

4.0

5.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

106

1063

1.00

0.00

1.7

2.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

109

1.01

0.00

1.3

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

147

1.02

0.00

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

1.00

0.00

4.4

7.3

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.02

-0.00

1.8

4.3

—

(40760409) HLA-A [Type] by High resolution

0.91

-0.00

1.0

—

(40763590) HLA-DQ beta [Type]

0.91

-0.00

1.0

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

(40760410) HLA-B [Type] by High resolution

0.91

-0.00

1.0

—

(3015057) Respiratory syncytial virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.91

-0.00

1.0

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

-0.00

0.0

2.7

—

3.57

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

5.9

—

(3025311) HLA-B [Type]

0.00

-0.00

0.0

1.0

—

(3004768) Phthalic anhydride IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_SYMPTOMS_SIGNS_INVOLVI_NERVOUS_MUSCULOS_SYSTEMS – Symptoms and signs involving the nervous and musculoskeletal systems

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Symptoms and signs involving the nervous and musculoskeletal systems

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Symptoms and signs involving the nervous and musculoskeletal systems (R18_SYMPTOMS_SIGNS_INVOLVI_NERVOUS_MUSCULOS_SYSTEMS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints